Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
8188 |
4. Check minimum number of eventsNone |
8188 |
5. Include endpointsNone |
8188 |
6. Filter based on genotype QC (FinnGen only) |
8188 |
Control definitions (FinnGen only)
- Control exclude
- F5_ORGANIC
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF3
Similar endpoints
↥List of similar endpoints to
Dementia in Alzheimer disease
based on the number of shared cases.
Similar with more cases:
- Unspecific neurodegenerative disorder
- Any dementia
- Any dementia, excluding more controls
- Dementia
- Dementia, including avohilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 128670 | 81960 | 45831 |
| Only index persons | 110175 | 71387 | 38788 |
| Unadjusted period prevalence (%) | |||
| Whole population | 1.96 | 2.35 | 1.28 |
| Only index persons | 2.22 | 2.62 | 1.48 |
| Median age at first event (years) | |||
| Whole population | 82.30 | 83.00 | 81.09 |
| Only index persons | 82.63 | 83.30 | 81.39 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 8188 | 3846 | 4342 |
| Unadjusted period prevalence (%) | 1.63 | 1.31 | 1.91 |
| Median age at first event (years) | 80.58 | 80.52 | 80.62 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 5794
- Matched controls
- 53800
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
196.0
323.0
1360
84
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
1041.6
323.0
1095
12
G30.0
ICD-10 Finland
Alzheimer disease with early onset
263.2
323.0
445
17
G30.8
ICD-10 Finland
Other Alzheimer disease
105.5
323.0
1014
108
N05AH04
ATC
quetiapine; oral
8.0
323.0
1423
2114
N06DX01
ATC
memantine; oral
546.7
323.0
3495
147
F06.7
ICD-10 Finland
Mild cognitive disorder
19.7
323.0
522
269
F009, G309
ICD-10 Finland
NA
+∞
323.0
353
*
N06DA02
ATC
donepezil; oral
317.7
323.0
2647
142
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
533.2
323.0
2511
77
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
7.2
323.0
1350
2171
N06DA04
ATC
galantamine; oral
236.3
323.0
811
37
F0019, G301
ICD-10 Finland
NA
+∞
323.0
524
*
N06DA03
ATC
rivastigmine; oral, transdermal
385.4
323.0
1703
58
G30.1
ICD-10 Finland
Alzheimer disease with late onset
117.4
323.0
2700
397
P70
ICPC
Dementia
49.1
323.0
789
172
P20
ICPC
Memory disturbance
9.3
323.0
2610
4362
SPAT1053
SPAT
Memory test
5.2
323.0
2460
6699
G30
ICD-10 Finland
Alzheimer disease
174.9
323.0
468
27
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
323.0
2794
*
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
464.4
323.0
420
9
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
820.2
323.0
701
9
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
+∞
323.0
503
*
F03
ICD-10 Finland
Unspecified dementia
51.2
323.0
1301
302
N05AX08
ATC
risperidone; systemic
22.8
323.0
1822
1062
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
135.5
323.0
1606
152
SPAT1245
SPAT
Provision of support and information to patient’s family members
6.4
292.8
846
1392
SPAT1234
SPAT
Support of social functional capacity
6.0
280.9
864
1537
SPAT1216
SPAT
Assessment of functional ability
3.1
248.3
1687
6216
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
4.4
239.6
996
2441
N05BA04
ATC
oxazepam; oral
2.9
232.3
1846
7496
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.0
227.6
1615
6069
F05.1
ICD-10 Finland
Delirium superimposed on dementia
1000.0
207.7
208
*
SPAT1254
SPAT
Administration of medicine
3.0
204.0
1443
5352
R53
ICD-10 Finland
Malaise and fatigue
2.7
199.9
1706
7115
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.4
193.3
2340
11797
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.4
191.6
1073
3347
F05.9
ICD-10 Finland
Delirium, unspecified
63.1
191.3
229
35
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
606.1
187.6
190
*
F0009, G300
ICD-10 Finland
NA
+∞
176.1
173
*
N06AX11
ATC
mirtazapine; oral
2.4
166.6
1857
8810
A28
ICPC
Limited function/disability NOS
2.5
162.9
1654
7452
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
158.2
1649
7513
R41.0
ICD-10 Finland
Disorientation, unspecified
5.9
150.4
456
772
AA1AD
NOMESCO Finland
CT of head and brain
2.3
147.5
1876
9374
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
144.7
2352
13097
N02BE01
ATC
paracetamol; systemic, rectal
2.3
144.5
4680
34785
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.8
140.1
1031
3809
F0029, G308
ICD-10 Finland
NA
+∞
139.3
137
*
N03AG01
ATC
valproic acid; systemic, rectal
5.6
130.2
406
709
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
128.2
1265
5501
N06AB10
ATC
escitalopram; oral
3.0
125.8
832
2850
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.9
120.9
542
1375
WYA20
NOMESCO Finland
Home visit
9.6
120.2
259
262
F0014, G301
ICD-10 Finland
NA
+∞
118.9
117
*
F001, G301
ICD-10 Finland
NA
552.5
115.1
117
*
N05AH03
ATC
olanzapine; systemic
6.6
113.0
311
461
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
+∞
112.7
111
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.8
106.7
493
1280
F01.9
ICD-10 Finland
Vascular dementia, unspecified
28.0
106.5
150
51
SPAT1360
SPAT
Extensive global examination
3.0
100.4
645
2148
F00
ICD-10 Finland
Dementia in Alzheimer disease
47.4
99.8
125
25
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
+∞
98.5
97
*
SPAT1301
SPAT
No procedures
1.9
98.2
2015
11793
SPAT1101
SPAT
Orthostatic test
3.3
96.9
539
1619
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
8.0
95.2
227
272
L28
ICPC
Limited function/disability (L)
2.1
94.9
1335
6728
TAB00
NOMESCO Finland
Lumbar puncture
6.1
93.9
271
427
SPAT1229
SPAT
Assessment of need for aid
2.6
93.4
771
2992
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
446.3
92.9
95
*
SPAT1304
SPAT
Counselling and guidance related to ageing
2.5
92.6
823
3325
N05BA06
ATC
lorazepam; systemic, sublingual
3.4
92.5
485
1391
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
92.5
1278
6385
SPAT1172
SPAT
Guidance concerning hydration
4.3
86.6
345
779
U04
ICPC
Incontinence urine
3.3
86.3
471
1391
R41.3
ICD-10 Finland
Other amnesia
4.8
84.6
302
610
Z75.5
ICD-10 Finland
Holiday relief care
7.8
84.4
205
253
A06AD11
ATC
lactulose; oral
2.0
83.0
1385
7415
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
82.7
1066
5135
N06AB04
ATC
citalopram; systemic
2.1
82.1
1153
5758
A04
ICPC
Weakness/tiredness general
2.2
82.1
948
4348
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.5
78.4
702
2831
SPAT1263
SPAT
Sampling
1.7
77.8
2262
14534
N05AD01
ATC
haloperidol; systemic
3.9
76.4
340
849
F00, F03
ICD-10 Finland
NA
+∞
75.1
74
*
S72.0
ICD-10 Finland
Fracture of neck of femur
2.8
73.2
506
1751
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.4
71.7
678
2806
SPAT1252
SPAT
Overall medication plan or its review
2.5
70.8
598
2327
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.1
65.4
395
1248
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
65.1
1801
11238
130
Kela drug reimbursment
Malignant tumour
0.3
64.7
111
3755
N06AX26
ATC
vortioxetine; oral
4.9
64.2
222
433
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
62.9
989
5108
N02AA05
ATC
oxycodone; systemic
1.9
62.0
1143
6249
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
7.1
61.3
157
210
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
3.3
60.9
333
980
SPAT1167
SPAT
Insertion of urinary catheter
2.9
56.8
372
1240
F0011, G301
ICD-10 Finland
NA
+∞
56.8
56
*
I95.1
ICD-10 Finland
Orthostatic hypotension
2.8
56.6
390
1341
SPAT1251
SPAT
Organisation of medication
3.0
56.4
359
1173
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
55.5
969
5172
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
2.6
55.5
453
1721
S01.0
ICD-10 Finland
Open wound of scalp
2.4
55.1
519
2130
S06.0
ICD-10 Finland
Concussion
2.3
54.9
576
2491
SPAT1246
SPAT
Screening of depression or other psychiatric problem
5.0
54.3
183
347
E86
ICD-10 Finland
Volume depletion
3.6
54.2
264
710
F05.8
ICD-10 Finland
Other delirium
80.4
52.2
60
7
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
51.7
1686
10858
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.9
51.0
335
1118
F009, F03
ICD-10 Finland
NA
+∞
49.7
49
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
48.9
1898
12733
R55
ICD-10 Finland
Syncope and collapse
1.9
48.4
828
4369
F00.11
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
456.8
48.0
49
*
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
47.5
703
10583
SPAT1262
SPAT
Handing over of treatment supplies
1.7
47.2
1067
6166
S70.0
ICD-10 Finland
Contusion of hip
2.9
47.0
314
1057
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.4
46.8
442
1813
F00.24
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type
229.3
46.6
49
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.5
46.5
385
1472
W19
ICD-10 Finland
Unspecified fall
2.1
46.0
571
2656
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
45.5
1518
9767
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
2.7
44.4
328
1176
F0024, G308
ICD-10 Finland
NA
+∞
43.6
43
*
N07AA05
ATC
NA
+∞
42.6
42
*
J01DB01
ATC
cefalexin; oral
1.5
41.4
3754
29870
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.2
40.7
227
677
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
14.6
40.6
70
45
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.2
40.6
229
687
F00.09
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking
+∞
40.5
40
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.2
40.4
222
655
C10AA01
ATC
simvastatin; oral
1.4
38.1
3006
23066
N30.0
ICD-10 Finland
Acute cystitis
1.8
37.7
767
4264
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.1
37.3
434
1958
R42
ICD-10 Finland
Dizziness and giddiness
1.6
37.0
1350
8799
H02AB02
ATC
dexamethasone; systemic
0.3
36.9
114
2934
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.9
36.7
604
3122
R4110
NOMESCO Finland
Physiotherapy
0.6
36.6
593
8799
F002, G308
ICD-10 Finland
NA
+∞
36.5
36
*
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
15.0
36.0
61
38
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
343.3
36.0
37
*
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
57.4
35.9
43
7
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.5
35.7
304
1179
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
35.7
397
1755
SPAT1139
SPAT
Nutrition survey
2.9
35.1
224
733
N05AD03
ATC
melperone; systemic
4.2
35.0
139
314
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
333.9
35.0
36
*
F00.12
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations
172.8
34.7
37
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
34.3
760
4326
N06AB06
ATC
sertraline; oral
2.3
34.3
333
1382
Z02.7
ICD-10 Finland
Issue of medical certificate
2.3
34.2
346
1463
SPAT1276
SPAT
Outlining of treatment with patient or their family members
3.1
34.2
194
586
R1250
NOMESCO Finland
Evaluation of functional capability
4.5
33.5
124
262
F00.2
ICD-10 Finland
Dementia in Alzheimer disease, atypical or mixed type
+∞
33.4
33
*
G04CA02
ATC
tamsulosin; oral
1.4
33.4
1913
13684
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.4
33.4
125
267
J01CA08
ATC
pivmecillinam; oral
1.5
33.1
1620
11222
SPAT1260
SPAT
Consultation of another employee
1.6
32.9
904
5466
AXX01
SPAT
NA
4.2
32.9
131
297
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
163.4
32.7
35
*
B03BA03
ATC
hydroxocobalamin; parenteral
1.9
32.5
485
2418
F00.13
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression
+∞
32.4
32
*
F22.0
ICD-10 Finland
Delusional disorder
5.5
32.2
98
167
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
31.2
1868
13427
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.6
30.9
244
907
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
30.8
771
4535
WX402
NOMESCO Finland
General anaesthesia
0.4
30.7
140
3079
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
3.0
30.3
187
600
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.7
30.2
654
3689
F0012, G301
ICD-10 Finland
NA
+∞
29.4
29
*
SPAT1279
SPAT
Preparation of immediate hospitalisation
3.9
29.0
125
305
SPAT1307
SPAT
Psychosocial counselling and guidance
3.5
28.5
137
367
F00.01
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism
+∞
28.4
28
*
Z29
ICPC
Social problem NOS
3.9
28.3
119
284
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.5
28.3
232
882
F00.21
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism
272.2
27.9
29
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
27.8
886
5543
F29
ICD-10 Finland
Unspecified nonorganic psychosis
5.1
27.7
90
166
A03FA01
ATC
metoclopramide; systemic, rectal
0.6
27.4
496
7221
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
6.0
27.1
77
121
SPAT1125
SPAT
Stoma care and guidance
3.0
27.0
158
490
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.7
26.2
184
640
XA800
NOMESCO Finland
Neuropsychological investigation
3.6
25.7
121
319
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.2
25.5
283
1249
N06AX16
ATC
venlafaxine; oral
2.0
25.1
335
1595
LAITO
NOMESCO Finland
NA
30.8
24.6
33
10
E0000UV
ATC
NA
1.4
24.5
1690
12338
F21
ICPC
NA
4.4
24.4
90
191
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.5
23.8
1038
6948
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
23.3
1995
15061
F0021, G308
ICD-10 Finland
NA
+∞
23.3
23
*
F00.22
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations
+∞
23.3
23
*
A29
ICPC
General symptom/complaint other
1.6
22.9
587
3463
A10AE04
ATC
insulin glargine; parenteral
1.7
22.8
487
2727
NF1AA
NOMESCO Finland
Hip X-ray examination
1.7
22.8
550
3187
TPH04
NOMESCO Finland
Cathetrisation of vein
0.6
22.8
545
7494
Z51.88
ICD-10 Finland
Other specified medical care
3.0
22.6
137
436
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
2.7
22.6
159
556
R33
ICD-10 Finland
Retention of urine
1.6
22.3
667
4093
SPAT1104
SPAT
Monitoring of emergency patient
1.8
22.3
381
1988
F01.2
ICD-10 Finland
Subcortical vascular dementia
13.5
22.3
39
27
F0013, G301
ICD-10 Finland
NA
+∞
22.3
22
*
F0022, G308
ICD-10 Finland
NA
+∞
22.3
22
*
N02AJ06
ATC
codeine and paracetamol; systemic
0.7
22.2
763
9789
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
22.1
1699
12579
SPAT1157
SPAT
Guidance concerning treatment of mouth and mucous membranes
3.8
22.1
95
233
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
0.1
22.0
11
797
F00.23
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression
214.3
22.0
23
*
SPAT1281
SPAT
Other administrative function
1.8
21.9
374
1949
Z51.5
ICD-10 Finland
Palliative care
1.8
21.8
428
2336
SPAT1284
SPAT
Extensive health certificate
2.9
21.8
136
441
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.2
21.7
219
926
G31.0
ICD-10 Finland
Circumscribed brain atrophy
9.3
21.5
45
45
SPAT1310
SPAT
Counselling related to known health issue
1.4
21.5
1410
10159
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
21.3
999
6766
F0004, G300
ICD-10 Finland
NA
+∞
21.3
21
*
F0023, G308
ICD-10 Finland
NA
+∞
21.3
21
*
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
3.3
21.3
109
309
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
11.3
21.2
40
33
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.2
21.1
25
1042
E000001
ATC
NA
1.5
20.9
881
5837
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
2.1
20.9
247
1119
-2
ICPC
NA
4.6
20.8
74
152
J01EA01
ATC
trimethoprim; systemic
1.4
20.6
1337
9603
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.0
20.6
288
1400
F009, G301
ICD-10 Finland
NA
+∞
20.3
20
*
2900A
ICD-9 Finland
Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated
+∞
20.3
20
*
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
+∞
20.3
20
*
WX002
NOMESCO Finland
Sedation and analgesia
0.6
20.3
507
6922
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.2
19.8
21
937
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
38.8
19.7
25
6
Z13.3
ICD-10 Finland
Special screening examination for mental and behavioural disorders
20.8
19.5
29
13
Z03
ICPC
Housing/neighbourhood problem
5.5
19.5
58
98
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
0.4
19.3
73
1730
F0024, G301
ICD-10 Finland
NA
+∞
19.2
19
*
A98
ICPC
Health maint/preventive medicine
1.3
19.2
3978
33670
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
14.9
19.2
32
20
R44.3
ICD-10 Finland
Hallucinations, unspecified
8.2
19.2
43
49
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.1
19.1
109
334
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.4
18.9
92
251
F00.29
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms
97.8
18.9
21
*
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.6
18.9
471
2755
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
22.9
18.7
27
11
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.4
18.6
101
2089
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
3.3
18.4
94
267
F01.0
ICD-10 Finland
Vascular dementia of acute onset
65.3
18.1
21
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.4
18.1
846
5711
N30.9
ICD-10 Finland
Cystitis, unspecified
1.9
18.1
293
1502
-
ICD-10 Finland
NA
2.6
18.0
138
509
A04AA02
ATC
granisetron; systemic, transdermal
0.3
17.5
44
1244
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
0.6
17.5
216
3470
N03AX14
ATC
levetiracetam; systemic
2.8
17.4
116
394
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.2
17.3
177
755
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.2
17.1
22
873
ZX120
NOMESCO Finland
Intravenous
0.5
17.1
182
3043
R50.9
ICD-10 Finland
Fever, unspecified
1.5
17.1
675
4403
F06.0
ICD-10 Finland
Organic hallucinosis
88.5
17.0
19
*
F00.04
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type
167.5
17.0
18
*
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.8
16.8
282
1464
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
16.7
1202
8737
P29
ICPC
Psychological sympt/compl other
2.9
16.5
103
338
L82
ICD-10 Finland
Seborrhoeic keratosis
0.6
16.4
339
4830
TPH07
NOMESCO Finland
Cathetrisation of artery
0.6
16.4
232
3607
G91.0
ICD-10 Finland
Communicating hydrocephalus
6.6
16.4
42
59
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.8
16.3
283
1484
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.4
16.3
136
525
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
16.2
172
748
N07AA06
ATC
NA
+∞
16.2
16
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
6.9
16.1
40
54
F00.0
ICD-10 Finland
Dementia in Alzheimer disease with early onset
158.2
16.0
17
*
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.2
15.8
84
247
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
15.8
2211
17604
A10AE05
ATC
insulin detemir; parenteral
1.9
15.7
252
1288
SPAT1325
SPAT
Vaccination
1.3
15.6
1924
15071
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.6
15.5
350
4897
A69
ICPC
General and Unspecified, Other reason for encounter NEC
2.2
15.4
158
675
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
0.7
15.4
613
7725
WX404
NOMESCO Finland
Intravenous generell anesthesy
0.6
15.4
360
5001
H02AA02
ATC
fludrocortisone; oral
3.5
15.1
72
195
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.2
15.0
16
707
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.0
14.8
85
263
R11
ICD-10 Finland
Nausea and vomiting
1.6
14.8
382
2252
WX408
NOMESCO Finland
General anesthesy, balanced
0.7
14.8
640
7957
G04CA01
ATC
alfuzosin; oral
1.4
14.6
729
4968
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
26.6
14.6
20
7
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
14.5
541
3481
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.9
14.4
200
970
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
14.3
2036
16180
L75
ICPC
Fracture: femur
2.5
14.3
111
413
G04BD08
ATC
solifenacin; oral
1.6
14.2
399
2401
Z60.8
ICD-10 Finland
Other problems related to social environment
6.9
14.2
35
47
F0019, G309
ICD-10 Finland
NA
+∞
14.2
14
*
F000, G300
ICD-10 Finland
NA
+∞
14.2
14
*
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.4
14.1
696
4729
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.7
14.0
482
6235
N05AB03
ATC
perphenazine; systemic, rectal
2.4
14.0
120
473
SPAT1138
SPAT
Guidance concerning bowel function
2.6
14.0
99
351
R74
ICPC
Upper respiratory infection acute
0.6
14.0
289
4120
SPAT1312
SPAT
General health counselling
1.3
13.8
1285
9664
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
5.1
13.7
43
79
SPAT1255
SPAT
Intravenous administration of medicine
1.7
13.7
318
1825
A04AA01
ATC
ondansetron; systemic, rectal
0.4
13.7
77
1568
Y94.0
ICD-10 Finland
Accident at home
2.5
13.7
111
425
P05
ICPC
Senility, feeling/behaving old
4.0
13.7
55
130
P04
ICPC
Feeling/behaving irritable/angry
11.6
13.7
25
20
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
13.6
377
2265
N29
ICPC
Neurological sympt/complt other
2.7
13.6
94
330
Z28
ICPC
Limited function/disability (Z)
4.7
13.6
46
92
K90
ICPC
Stroke/cerebrovascular accident
1.9
13.5
189
920
L08
ICPC
Shoulder symptom/complaint
0.7
13.5
400
5316
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
49.6
13.3
16
*
SPAT1050
SPAT
Extensive neurological examination
2.3
13.3
118
474
N28
ICPC
Limited function/disability (N)
2.7
13.3
88
301
C04AE01
ATC
ergoloid mesylates; systemic
3.0
13.3
76
236
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.0
13.2
75
231
3310A
ICD-9 Finland
Other cerebral degenerations, Alzheimer's disease
+∞
13.2
13
*
G72.8
ICD-10 Finland
Other specified myopathies
2.5
13.2
104
392
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.5
13.1
527
3442
G04CB02
ATC
dutasteride; oral
1.5
13.1
472
3014
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
0.7
12.9
345
4670
GD1AA
SPAT
NA
0.2
12.9
10
538
K08.3
ICD-10 Finland
Retained dental root
1.7
12.8
289
1644
XF402
NOMESCO Finland
ECG with work load test
0.6
12.8
278
3918
S01
ICD-10 Finland
Open wound of head
3.0
12.7
71
218
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
6.3
12.6
33
49
W06
ICD-10 Finland
Fall involving bed
3.2
12.5
66
195
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.3
12.5
32
896
XF400
NOMESCO Finland
ECG with 12 standard connections
0.7
12.5
624
7607
WX302
NOMESCO Finland
Thoracal epidural anesthesy
0.4
12.4
58
1262
N05CD07
ATC
temazepam; oral
1.3
12.3
873
6302
AA1AA
NOMESCO Finland
Head X-ray examination
3.5
12.3
56
148
R32
ICD-10 Finland
Unspecified urinary incontinence
2.0
12.2
152
711
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.8
12.2
834
9741
F0009, G309
ICD-10 Finland
NA
+∞
12.1
12
*
F009, G308
ICD-10 Finland
NA
+∞
12.1
12
*
F0001, G300
ICD-10 Finland
NA
+∞
12.1
12
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
0.1
12.1
5
410
J96.1
ICD-10 Finland
Chronic respiratory failure
0.4
12.0
48
1110
C03CA01
ATC
furosemide; systemic
1.2
11.9
2479
20418
K59.0
ICD-10 Finland
Constipation
1.6
11.9
334
2011
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
6.9
11.9
29
39
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.4
11.9
688
4805
G20
ICD-10 Finland
Parkinson disease
1.9
11.8
181
915
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
2.2
11.8
116
492
K80
ICPC
Cardiac arrhythmia NOS
0.6
11.7
130
2148
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.8
11.7
206
1089
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.0
11.7
147
689
Z11
ICPC
Compliance/being ill problem
4.0
11.6
46
108
N06AX21
ATC
duloxetine; oral
1.6
11.6
300
1771
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
0.5
11.6
85
1582
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.9
11.6
167
824
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
0.7
11.5
302
4106
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
0.6
11.5
205
3021
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
0.6
11.5
259
3629
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
2.1
11.5
128
570
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.7
11.5
561
6874
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.6
11.5
190
2844
XKD00
NOMESCO Finland
Uroflowmetry
1.3
11.5
1038
7753
EB1AA
SPAT
NA
0.3
11.5
17
621
S22.3
ICD-10 Finland
Fracture of rib
1.6
11.4
307
1831
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
5.1
11.3
35
64
JN4BD
NOMESCO Finland
Extensive body CT
0.7
11.3
275
3796
G04BD07
ATC
tolterodine; oral
1.6
11.2
325
1976
N18
ICPC
Paralysis/weakness
2.2
11.2
111
469
P99
ICPC
Psychological disorders other
3.9
11.1
45
108
F0021, G301
ICD-10 Finland
NA
+∞
11.1
11
*
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
2.2
11.1
111
473
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
3.4
11.1
53
146
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
2.9
11.0
65
209
N05AH02
ATC
clozapine; systemic
6.1
11.0
29
44
WX100
NOMESCO Finland
Conjunctival surface anesthesia
0.7
11.0
428
5428
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
11.0
10.8
20
17
L01BC06
ATC
capecitabine; oral
0.4
10.7
32
833
R03BB01
ATC
ipratropium bromide; inhalant
0.6
10.7
194
2845
T89
ICPC
Diabetes insulin dependent
2.3
10.7
95
384
L15
ICPC
Knee symptom/complaint
0.7
10.7
482
5978
R05
ICPC
Cough
0.7
10.7
487
6029
L03AA02
ATC
filgrastim; parenteral
0.3
10.7
16
582
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
10.7
386
2466
4148X
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]
0.2
10.7
14
548
N99
ICPC
Neurological disease other
3.0
10.6
58
178
F09
ICD-10 Finland
Unspecified organic or symptomatic mental disorder
40.3
10.5
13
*
D07AA02
ATC
hydrocortisone; topical
1.4
10.5
503
3398
WX704
NOMESCO Finland
Intubation
0.5
10.5
83
1510
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
2.6
10.5
77
280
UGC12
NOMESCO Finland
Flexible bronchoscopy
0.7
10.5
255
3516
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.4
10.4
49
134
Y94.1
ICD-10 Finland
Accident in connection with service housing
11.1
10.3
19
16
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.6
10.3
251
1464
Z08
ICPC
Social welfare problem
3.2
10.3
52
151
N05AA02
ATC
levomepromazine; systemic
1.8
10.2
170
886
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
0.3
10.2
24
694
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
2.3
10.2
94
388
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
+∞
10.1
10
*
A10BB12
ATC
glimepiride; oral
1.4
10.1
527
3614
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
102.3
10.1
11
*
L57.0
ICD-10 Finland
Actinic keratosis
0.7
10.0
388
4926
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
0.4
10.0
33
820
L12
ICPC
Hand/finger symptom/complaint
0.7
10.0
244
3359
WF002
NOMESCO Finland
Radical radiotherapy
0.5
9.9
73
1358
R54
ICD-10 Finland
Senility
3.5
9.9
45
120
M01AC06
ATC
meloxicam; systemic, rectal
1.2
9.9
1379
10839
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.4
9.9
37
876
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
0.7
9.8
442
5486
R03AC02
ATC
salbutamol; inhalant
0.8
9.8
1669
17701
Z75.0
ICD-10 Finland
Medical services not available in home
5.4
9.7
28
48
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
0.2
9.7
9
427
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.4
9.7
537
3721
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
0.1
9.6
6
370
WX111
NOMESCO Finland
Local infiltration anesthesia
0.3
9.6
27
722
J01CA04
ATC
amoxicillin; systemic
1.2
9.6
3338
28639
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.8
9.6
942
10565
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
0.4
9.5
52
1066
DFF00
NOMESCO Finland
Pure tone audiometry
0.6
9.5
202
2866
4289X
ICD-9 Finland
Heart failure, unspecified
0.2
9.5
6
366
A01
ICPC
Pain general/multiple sites
1.5
9.4
325
2056
S00.0
ICD-10 Finland
Superficial injury of scalp
2.1
9.4
101
446
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.4
9.3
42
925
N02AX02
ATC
tramadol; systemic, rectal
0.8
9.3
1586
16835
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.2
9.3
88
369
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
9.3
370
2417
R03DA04
ATC
theophylline; systemic, rectal
0.7
9.3
268
3578
P28
ICPC
Limited function/disability (P)
4.7
9.3
30
59
SPAT1111
SPAT
Planning of analgesia
2.6
9.2
64
229
F01
ICD-10 Finland
Vascular dementia
5.8
9.2
25
40
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
0.3
9.1
26
690
Z01.9
ICD-10 Finland
Special examination, unspecified
1.6
9.1
210
1207
H02AB07
ATC
prednisone; oral
0.7
9.1
464
5660
F07.8
ICD-10 Finland
Other organic personality and behavioural disorders due to brain disease, damage and dysfunction
93.0
9.1
10
*
F00.02
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions
93.0
9.1
10
*
N03AF02
ATC
oxcarbazepine; oral
2.0
9.1
108
498
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.6
9.1
214
1237
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.7
9.0
201
1145
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
0.4
9.0
33
787
NFB10
NOMESCO Finland
Primary partial prosthetic replacement of hip joint not using cement, other or unspecified
3.5
9.0
40
106
S32.8
ICD-10 Finland
Fracture of other and unspecified parts of lumbar spine and pelvis
2.4
8.9
71
273
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.2
8.9
1727
14011
L76
ICPC
Fracture: other
1.8
8.9
139
711
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.6
8.9
217
1269
L17
ICPC
Foot/toe symptom/complaint
0.8
8.8
701
8071
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
4.1
8.8
33
75
KMAK
NOMESCO Finland
NA
1.2
8.8
1489
11916
HA1RA
SPAT
NA
0.0
8.8
*
233
H01
ICPC
Ear pain/earache
0.6
8.8
121
1891
N05CF01
ATC
zopiclone; oral
1.2
8.8
1786
14554
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
0.6
8.8
111
1772
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
5.2
8.7
26
47
WW500
NOMESCO Finland
Blood transfusion
0.5
8.6
67
1221
J01MA02
ATC
ciprofloxacin; systemic
1.2
8.6
1982
16335
C03DA01
ATC
spironolactone; oral
0.7
8.5
418
5126
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.7
8.5
306
3936
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.8
8.5
51
168
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
1.8
8.4
132
678
T93
ICPC
Lipid disorder
0.5
8.4
79
1362
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
8.4
258
1595
SPAT1127
SPAT
Enema
2.5
8.4
64
240
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.6
8.3
227
1365
SPAT1097
SPAT
Recording of ECG
1.3
8.3
741
5508
S18
ICPC
Laceration/cut
0.8
8.3
1451
15408
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
0.2
8.3
11
424
M05BA02
ATC
clodronic acid; systemic
0.0
8.3
*
224
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
0.4
8.2
26
660
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.8
8.2
701
8007
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.5
8.2
54
1039
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
0.3
8.2
13
454
F01.24
ICD-10 Finland
Subcortical vascular dementia other additional symptoms of mixed type
83.7
8.2
9
*
SPAT1313
SPAT
Guidance and counselling related to accident prevention
3.1
8.1
43
131
F06.8
ICD-10 Finland
Other specified mental disorders due to brain damage and dysfunction and to physical disease
+∞
8.1
8
*
F0022, G301
ICD-10 Finland
NA
+∞
8.1
8
*
A23
ICPC
Risk factor NOS
1.7
8.1
159
875
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
8.1
3374
29187
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
0.3
8.0
16
499
ZX090
NOMESCO Finland
Other technic of radiotherapy
0.4
8.0
30
708
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
1.6
8.0
182
1047
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
1.9
7.9
106
515
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
0.6
7.9
113
1749
G04BD11
ATC
fesoterodine; oral
1.7
7.9
166
931
DJA10
NOMESCO Finland
Biopsy of septum of nose
10.0
7.9
15
14
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
0.6
7.9
89
1457
XF606
SPAT
NA
6.2
7.8
20
30
D07BC01
ATC
betamethasone and antiseptics; topical
1.3
7.8
497
3521
ZYC01
SPAT
NA
1.7
7.8
141
757
P15
ICPC
Chronic alcohol abuse
2.8
7.8
47
156
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.9
7.8
113
567
Z74.1
ICD-10 Finland
Need for assistance with personal care
15.9
7.7
12
7
Z60.9
ICD-10 Finland
Problem related to social environment, unspecified
4.7
7.7
25
50
T03
ICPC
Loss of appetite
4.7
7.7
25
50
G04BD10
ATC
darifenacin; oral
2.8
7.7
46
152
JN4AD
NOMESCO Finland
Body CT examination
0.6
7.6
161
2283
F32
ICD-10 Finland
Depressive episode
1.9
7.6
109
542
SPAT1165
SPAT
Peritoneal dialysis
5.6
7.6
21
35
S28
ICPC
Limited function/disability (S)
3.4
7.6
34
92
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
0.5
7.5
56
1036
XJH00
NOMESCO Finland
Transanal ultrasonography
1.3
7.5
455
3201
E44.1
ICD-10 Finland
Mild protein-energy malnutrition
12.1
7.5
13
10
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.8
7.4
755
8462
TPX10
NOMESCO Finland
Implantation of vascular injection port
0.4
7.4
24
600
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
0.2
7.4
8
348
I95.9
ICD-10 Finland
Hypotension, unspecified
2.0
7.3
86
397
M02AA07
ATC
piroxicam; topical
1.2
7.3
1772
14610
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
2.2
7.3
72
310
WX110
SPAT
NA
0.3
7.3
20
537
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
0.5
7.3
60
1073
K04
ICPC
Palpitations/awareness of heart
0.5
7.2
67
1161
D07AC01
ATC
betamethasone; topical
1.2
7.2
1412
11427
SPAT1240
SPAT
Therapeutic discussion
1.6
7.2
185
1096
I21.2
ICD-10 Finland
Acute transmural myocardial infarction of other sites
0.2
7.2
7
322
F01.1
ICD-10 Finland
Multi-infarct dementia
74.4
7.2
8
*
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
0.3
7.2
20
530
F10.73
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol dementia
7.4
7.2
16
20
-1
ICD-10 Finland
NA
2.1
7.1
73
319
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
7.1
621
4601
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.2
7.1
1315
10587
F0002, G300
ICD-10 Finland
NA
+∞
7.1
7
*
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
7.1
7
*
F00.03
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression
+∞
7.1
7
*
F0010, G308
ICD-10 Finland
NA
+∞
7.1
7
*
F0289, G318
ICD-10 Finland
NA
+∞
7.1
7
*
T90
ICPC
Diabetes non-insulin dependent
1.2
7.1
1047
8244
WX892
NOMESCO Finland
Monitored bed care
0.7
7.1
177
2423
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
0.4
7.0
26
616
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
3.8
7.0
28
69
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
0.5
7.0
61
1073
Z50.1
ICD-10 Finland
Other physical therapy
0.6
7.0
98
1521
WX212
NOMESCO Finland
Femoral plexus blockade
1.8
7.0
106
539
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.3
7.0
493
3552
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
0.2
6.9
8
334
R03AK07
ATC
formoterol and budesonide; inhalant
0.8
6.9
385
4642
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
2.4
6.9
55
212
R45.5
ICD-10 Finland
Hostility
27.9
6.9
9
*
A05
ICPC
Feeling ill
1.7
6.9
146
824
S82
ICPC
Naevus/mole
0.7
6.9
230
2990
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.3
6.9
606
4499
EBA30
NOMESCO Finland
Excision of root of tooth
1.5
6.8
201
1231
N87
ICPC
Parkinsonism
2.2
6.8
63
263
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.5
6.8
207
1279
S72.2
ICD-10 Finland
Subtrochanteric fracture
2.2
6.8
63
264
K03.66
ICD-10 Finland
Tooth plaque
1.5
6.8
190
1151
SPAT1107
SPAT
Extensive external surface anaesthesia of skin with cream or gel
3.9
6.8
26
62
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
0.5
6.8
42
820
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
0.4
6.8
20
517
90621
NOMESCO Finland
NA
3.4
6.8
30
81
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
0.6
6.8
140
1989
G04BD04
ATC
oxybutynin; oral, transdermal
1.4
6.7
329
2236
XG460
NOMESCO Finland
Short time oxymetry
0.4
6.7
35
726
201
Kela drug reimbursment
Chronic cardiac insufficiency
0.7
6.7
259
3290
A11CC03
ATC
alfacalcidol; systemic
0.4
6.7
34
711
R63.4
ICD-10 Finland
Abnormal weight loss
1.6
6.7
170
1006
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.4
6.7
294
1961
XF404
NOMESCO Finland
Ambulatory ECG
0.7
6.7
266
3360
K22
ICPC
Risk factor cardiovascular disease
0.6
6.6
110
1639
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.2
6.6
942
7386
B01AB10
ATC
tinzaparin; parenteral
0.6
6.6
132
1891
WZC30
NOMESCO Finland
Teaching
0.7
6.6
262
3316
M04AA01
ATC
allopurinol; systemic
0.8
6.6
619
7001
EB1SA
SPAT
NA
0.2
6.6
7
306
LCA06
NOMESCO Finland
Biopsy of endometrium
0.6
6.6
98
1498
N03AX18
ATC
lacosamide; systemic
5.2
6.6
19
34
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
2.3
6.6
56
226
S21
ICPC
Skin texture symptom/complaint
0.7
6.6
300
3715
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
0.3
6.5
18
481
R44.1
ICD-10 Finland
Visual hallucinations
3.6
6.5
27
69
N06AX12
ATC
bupropion; oral
2.2
6.5
59
246
Z43.5
ICD-10 Finland
Attention to cystostomy
2.6
6.5
43
152
G04BD12
ATC
mirabegron; oral
1.3
6.5
499
3637
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
6.5
382
2675
K59.09
ICD-10 Finland
Constipation, unspecified
1.4
6.5
306
2068
N05AX12
ATC
aripiprazole; systemic
3.0
6.5
35
110
S20.2
ICD-10 Finland
Contusion of thorax
1.5
6.4
183
1114
L02BB03
ATC
bicalutamide; oral
0.6
6.4
123
1775
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.3
6.4
536
3950
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.2
6.4
702
5347
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
2.1
6.4
68
303
SPAT1014
SPAT
Treatment of eyes
1.9
6.4
92
462
S29
ICPC
Skin symptom/complaint other
0.8
6.4
449
5253
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
1.7
6.4
135
763
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
6.4
189
1163
A27
ICPC
Fear of other disease NOS
1.5
6.4
178
1078
WX872
NOMESCO Finland
Intensive care
0.6
6.4
84
1321
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.9
6.4
83
400
A46
ICD-10 Finland
Erysipelas
1.2
6.4
694
5280
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.6
6.4
151
881
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
1.8
6.4
101
525
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
0.1
6.4
*
225
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.5
6.4
212
1340
S97
ICPC
Chronic ulcer skin
1.4
6.4
284
1901
L99
ICPC
Musculoskeletal disease other
1.9
6.3
81
390
R03BA02
ATC
budesonide; inhalant
0.8
6.3
453
5285
F32.1
ICD-10 Finland
Moderate depressive episode
2.0
6.3
70
319
S09.9
ICD-10 Finland
Unspecified injury of head
2.4
6.3
51
199
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
2.5
6.3
48
182
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.1
6.3
67
299
F02.89
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without information of additional symptoms
11.4
6.3
11
9
SPAT1243
SPAT
Psychiatric/psychological examination
3.0
6.3
33
102
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
3.0
6.3
33
102
Z51.4
ICD-10 Finland
Preparatory care for subsequent treatment, not elsewhere classified
2.3
6.3
55
227
SPAT1285
SPAT
Provision of consultation response
1.5
6.3
218
1388
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.3
6.3
457
3307
S52.5
ICD-10 Finland
Fracture of lower end of radius
1.3
6.3
365
2553
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
6.0
6.2
16
25
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
1.6
6.2
157
931
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
1.9
6.2
82
402
F10.24
ICD-10 Finland
Alcohol depence active use
3.4
6.2
27
73
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.8
6.1
24
59
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
2.0
6.1
73
343
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
4.1
6.1
22
50
N05AN01
ATC
lithium; oral
2.4
6.1
47
180
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
13.3
6.1
10
7
UJF30
NOMESCO Finland
Ileoscopy through colon
0.7
6.1
165
2228
F99
ICD-10 Finland
Mental disorder, not otherwise specified
3.0
6.1
32
99
S01.41
ICD-10 Finland
Open wound in the temple-jaw region
2.6
6.1
40
141
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
0.4
6.1
25
564
Z00.0
ICD-10 Finland
General medical examination
1.2
6.1
739
5694
F0029, G301
ICD-10 Finland
NA
+∞
6.1
6
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
0.2
6.1
5
253
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
1.6
6.1
146
855
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
5.7
6.1
16
26
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
0.7
6.0
209
2704
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
4.9
6.0
18
34
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019309) Folate [Moles/volume] in Red Blood Cells
3013
12300
2.79
307.65
2.2
1.8
nmol/l
1417.8
1145.8
37.41
2036
8938
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
269
136
17.48
295.53
1.0
1.0
ng/l
59.3
39.6
3.55
166
79
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
269
136
17.48
295.53
1.0
1.0
ng/l
533.5
700.4
4.19
157
78
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
264
136
17.14
287.51
1.0
1.0
ng/l
426.2
286.4
4.29
162
81
(3029937) Albumin [Presence] in Urine by Test strip
2530
11969
2.20
204.71
5.5
4.8
estimate
0.0
0.0
0.88
608
3884
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2410
11583
2.13
183.50
1.9
1.7
pmol/l
432.1
19423301.9
5.12
1784
9010
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2947
16515
1.85
134.75
5.6
5.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
319
606
4.65
125.99
1.2
1.3
mg/l
483.0
601.6
4.03
285
579
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
281
504
4.91
118.69
1.3
1.4
e6/l
290.3
896.2
1.34
249
423
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
281
504
4.91
118.69
1.2
1.3
e6/l
19.2
31.1
0.32
243
404
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3490
21269
1.73
114.53
5.0
4.7
ng/l
58.2
89.6
0.95
2866
17228
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1367
6189
2.08
114.38
10.8
9.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
220
325
5.93
114.37
2.8
3.4
umol/l
311.2
326.7
0.65
159
265
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
279
523
4.69
111.88
1.2
1.2
mmol/l
4.0
3.9
0.14
262
481
(3019150) Specific gravity of Urine by Refractometry
1901
9746
1.88
110.81
6.0
4.9
kg/l
1.0
1.0
1.08
145
1674
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
471
10025
0.36
102.84
1.5
1.6
mmol/l
1.2
1.3
0.21
325
8152
(40761535) Cells panel - Urine sediment
1011
4382
2.12
93.41
4.2
3.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
2774
17058
1.61
78.80
2.4
3.2
mmol/l
2.3
2.4
2.34
2185
14126
(40768804) Tissue Pathology biopsy report
1287
17454
0.56
76.95
2.1
2.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
220
483
3.98
72.12
1.2
1.3
—
—
—
0
0
(3015736) pH of Urine
2780
17537
1.55
68.10
5.1
4.1
—
5.9
—
0
12
(3031040) Bacteria [#/volume] in Urine by Automated count
4522
32068
1.49
60.93
6.6
5.7
e6/l
3310.7
1623.6
1.67
288
558
(3035350) Ketones [Presence] in Urine by Test strip
3266
21919
1.47
56.29
5.3
4.4
estimate
0.0
0.0
0.00
689
4175
(3033658) Prothrombin time (PT) actual/Normal
850
11939
0.56
53.68
3.1
4.0
%
77.6
79.5
1.29
798
11652
(3020682) Albumin/Creatinine [Ratio] in Urine
1274
16123
0.61
53.54
3.2
3.9
mg/mmol
11.9
10.1
0.46
742
10184
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1751
10430
1.56
52.59
3.0
3.0
mmol/l
2.5
2.5
6.68
1483
8853
(3012516) Albumin [Mass/volume] in Urine
1181
15149
0.61
52.24
2.6
3.2
mg/l
358.2
345.4
0.04
694
9716
(3021601) Nitrite [Presence] in Urine by Test strip
3237
21923
1.45
51.77
6.3
6.0
estimate
0.0
0.0
0.00
663
4134
(3009508) Creatinine [Moles/volume] in Urine
1189
15147
0.61
50.81
2.5
3.1
mmol/l
7.0
6.5
3.28
844
12168
(3009261) Glucose [Presence] in Urine by Test strip
3259
22214
1.44
49.68
5.4
4.5
estimate
0.0
0.0
0.50
664
4128
(3026008) Bacteria identified in Urine by Culture
2787
18504
1.45
48.61
4.0
3.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1059
5712
1.68
47.21
2.6
2.5
ug/l
4.8
6.0
1.50
686
4736
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
714
3441
1.85
47.00
1.5
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1829
20806
0.67
44.50
4.2
5.4
%
61.6
60.1
4.55
1558
18965
(3023368) Bacteria identified in Blood by Culture
2523
16670
1.44
44.03
3.8
4.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
1846
20839
0.68
42.58
4.2
5.4
%
2.7
2.8
0.27
1574
18993
(3022096) Basophils/100 leukocytes in Blood
1790
20323
0.68
42.57
4.3
5.4
%
0.6
0.6
3.80
1523
18550
(3019069) Monocytes/100 leukocytes in Blood
1861
20932
0.68
41.90
4.7
5.7
%
8.8
9.1
2.51
1593
19109
(3014271) Vancomycin [Susceptibility]
172
477
3.13
39.80
3.6
3.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1007
5596
1.62
39.42
5.1
4.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1923
21217
0.70
37.70
4.5
5.6
%
23.4
24.3
2.44
1633
19227
(3043409) Potassium [Moles/volume] in Arterial blood
408
1750
2.05
37.61
2.8
3.9
mmol/l
3.9
3.9
0.10
342
1616
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
871
11230
0.62
37.11
4.3
4.5
ng/l
152.7
495.0
3.68
753
10161
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
629
8787
0.58
37.09
3.4
3.2
e6/l
2.9
2.7
0.39
399
4991
(42870588) Differential panel, method unspecified - Blood
1376
15892
0.68
33.90
4.0
5.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1744
11220
1.42
33.41
4.8
4.4
—
—
—
0
0
(4035726)
225
4194
0.44
32.59
1.2
1.3
—
—
—
0
0
(3000492) Spirometry study
119
2890
0.34
31.89
1.4
1.6
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
442
2070
1.88
31.54
2.8
3.6
mmol/l
1.5
1.5
0.00
434
2025
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3838
37468
0.75
31.51
3.9
4.7
mmol/l
1.4
1.4
0.50
2970
32744
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
714
9311
0.62
31.27
2.9
3.0
e6/l
1.9
1.4
1.45
475
5465
(3001604) Monocytes [#/volume] in Blood
2046
21788
0.73
30.22
3.8
5.1
e9/l
0.6
0.6
1.33
1723
18167
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3909
37963
0.76
30.18
3.9
4.8
mmol/l
4.2
4.3
0.84
3055
33507
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
120
319
3.25
29.84
2.5
2.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
2068
21944
0.73
29.68
3.8
5.1
e9/l
0.0
0.0
2.41
1736
18340
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2269
15571
1.35
28.53
2.3
2.1
u/l
249.0
217.8
0.85
2026
14389
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4105
39395
0.77
27.51
4.2
5.5
mmol/l
2.4
2.4
1.10
3213
34617
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
353
5356
0.54
27.42
1.1
1.2
u/ml
9.5
16.1
1.56
127
1724
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5312
41190
1.33
27.32
19.8
19.9
mg/l
31.4
28.9
4.64
4544
34924
(3021589) Normoblasts [#/volume] in Blood
1749
18842
0.73
27.01
11.7
10.8
e9/l
0.0
0.0
1.35
1489
15139
(3024561) Albumin [Mass/volume] in Serum or Plasma
3138
22700
1.31
26.78
3.5
4.3
g/l
33.7
33.7
0.28
2642
20637
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
407
1957
1.82
26.69
1.2
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
426
6081
0.58
26.53
1.4
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
2166
22564
0.75
26.43
3.9
5.2
e9/l
0.2
0.2
0.28
1774
19082
(3051387) C reactive protein [Mass/volume] in Capillary blood
288
1238
2.03
26.39
3.8
3.9
mg/l
32.0
30.3
0.30
223
829
(3020891) Body temperature
460
2319
1.74
25.69
3.4
4.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
803
4657
1.53
25.48
3.3
3.6
mmol/l
1.2
1.2
0.84
615
4029
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3755
36260
0.78
25.14
3.5
4.2
mmol/l
1.2
1.2
0.20
2856
31298
(3023410) Appearance of Cerebral spinal fluid
85
203
3.61
24.95
1.2
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
692
3911
1.56
24.64
5.0
4.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
2152
22273
0.76
24.46
3.9
5.2
e9/l
1.7
1.9
2.11
1818
18895
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
171
3151
0.45
23.84
4.5
6.8
mmol/l
24.0
24.4
0.60
136
2862
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
465
6302
0.61
23.41
3.5
3.3
ng/l
263.5
313.1
1.59
417
5777
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
277
4308
0.53
23.24
2.2
2.4
u/l
28.3
36.4
4.44
216
3620
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
414
5726
0.60
22.60
1.1
1.2
iu/ml
51.4
42.4
0.38
105
1749
(3026493) Urate [Moles/volume] in Serum or Plasma
1112
12540
0.72
22.07
2.3
2.9
umol/l
6384.4
7981.0
0.43
800
10333
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
483
6332
0.63
20.94
2.5
3.6
ug/l
33.1
26.6
0.18
371
5311
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
165
2921
0.47
20.56
5.8
7.7
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
187
759
2.13
20.02
10.1
8.6
mmol/l
8.0
7.3
1.46
153
624
(4034850)
285
1343
1.84
19.97
9.4
13.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
477
6170
0.64
19.38
1.5
1.5
g/l
3.0
2.8
0.48
251
3292
(3037522) Nuclear Ab [Titer] in Serum
304
4374
0.58
19.25
1.2
1.3
titre
422.0
527.6
0.62
60
1036
(3013650) Neutrophils [#/volume] in Blood by Automated count
2575
25484
0.80
18.65
5.1
7.8
e9/l
4.9
4.5
8.03
2193
21758
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2496
18206
1.25
17.69
2.1
2.2
nmol/l
77.4
81.3
7.96
1894
15455
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
587
7145
0.68
17.59
2.6
3.4
u/l
247.5
251.4
0.24
471
6616
(3030981) Hyaline casts [#/volume] in Urine by Automated count
538
3096
1.52
17.54
3.7
2.9
e6/l
0.5
0.4
0.51
530
3046
(3002385) Erythrocyte distribution width [Ratio]
3309
31703
0.81
17.15
22.2
24.4
%
14.2
14.2
0.40
3138
30827
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
396
5166
0.64
16.62
2.3
2.5
umol/l
13.3
10.4
0.84
282
4459
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2278
16535
1.25
16.60
2.4
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1475
10156
1.30
16.55
1.8
1.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
1021
11207
0.74
16.29
4.3
6.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
5180
41070
1.24
16.11
21.0
19.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
5427
43248
1.24
16.09
23.5
24.4
mmol/l
139.7
139.3
11.84
5046
41916
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
22
941
0.20
15.99
2.1
2.1
%
203.8
214.7
0.32
22
881
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1084
11768
0.75
15.96
2.2
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2123
21209
0.80
15.92
4.2
4.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
483
5993
0.67
15.90
1.2
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
5429
43286
1.24
15.90
23.5
24.6
mmol/l
4.0
4.0
0.07
5030
41877
(3003694) ABO and Rh group [Type] in Blood
836
9424
0.73
15.89
1.3
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
5456
43535
1.24
15.80
27.5
29.3
e9/l
7.5
7.2
5.37
5047
41702
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1142
12291
0.76
15.77
2.5
2.9
u/l
34.0
36.9
1.04
1011
11432
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3162
23881
1.22
15.65
4.7
5.8
mmol/l
1.2
1.2
0.63
2570
21208
(3035941) MCH [Entitic mass]
5451
43525
1.24
15.48
27.3
29.2
pg
30.3
30.4
2.68
5097
42424
(3024731) MCV [Entitic volume]
5451
43526
1.24
15.47
27.4
29.2
fl
91.9
92.1
1.29
5100
42422
(3026361) Erythrocytes [#/volume] in Blood
5451
43526
1.24
15.47
27.5
29.3
e12/l
4.2
4.3
26.39
5043
41683
(3007461) Platelets [#/volume] in Blood
5450
43519
1.24
15.46
27.4
29.3
e9/l
237.5
235.1
1.65
5063
41895
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
189
2921
0.54
15.45
1.3
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
5451
43533
1.24
15.41
27.7
29.5
g/l
126.4
128.9
27.30
5097
42447
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
66
186
3.05
15.11
1.5
2.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
66
186
3.05
15.11
1.5
2.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
85
1716
0.42
15.03
1.6
2.4
g/l
0.0
0.0
0.00
67
1557
(3037467) Urinalysis macro (dipstick) panel - Urine
4095
31835
1.21
14.78
5.3
5.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
73
221
2.84
14.76
1.2
1.2
mmol/l
2.0
2.3
1.37
66
199
(36660697) Celiac disease serology panel - Serum
148
2424
0.51
14.64
1.3
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
158
2533
0.52
14.59
1.2
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
166
2592
0.54
14.06
1.5
2.2
g/l
3.7
3.7
0.01
86
1769
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
915
10002
0.75
13.93
2.8
3.5
ug/l
0.9
0.9
0.24
605
7381
(3020779) Urea [Moles/volume] in Serum or Plasma
437
5392
0.67
13.91
3.9
5.5
mmol/l
12.5
12.8
0.28
368
4997
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
92
1744
0.44
13.88
1.5
2.3
g/l
0.0
0.0
1.01
67
1563
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
118
2044
0.49
13.85
1.7
2.7
u/ml
813.9
3363.8
1.09
86
1721
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
102
1854
0.46
13.74
1.5
2.3
g/l
0.0
0.0
1.72
76
1664
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
169
2599
0.55
13.59
1.5
2.2
g/l
7.3
7.6
0.79
90
1829
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
169
2595
0.55
13.52
1.5
2.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
158
2470
0.54
13.44
1.5
2.2
g/l
10.7
10.5
0.15
94
2009
(3008152) Bicarbonate [Moles/volume] in Arterial blood
603
3738
1.41
13.37
4.8
6.1
mmol/l
24.5
24.5
0.00
581
3493
(3030467) Casts [#/volume] in Urine by Automated count
1467
15026
0.80
13.21
3.3
3.5
e6/l
0.7
0.6
1.00
1237
11607
(3044889) 12 lead EKG panel
3199
30309
0.83
13.17
4.5
4.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1520
10776
1.26
13.10
5.7
4.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
44
1105
0.34
12.75
1.9
2.1
g/l
3.5
3.6
0.19
38
1030
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
752
8351
0.74
12.69
2.3
2.6
%
19.5
20.5
1.17
518
6993
(3012501) Base excess in Blood by calculation
260
1364
1.65
12.62
3.8
4.5
mmol/l
2.7
3.0
0.77
172
915
(3013290) Carbon dioxide [Partial pressure] in Blood
260
1365
1.65
12.59
3.8
4.5
kpa
5.0
5.0
0.23
246
1321
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
213
3013
0.59
12.59
1.3
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4068
37635
0.84
12.43
19.0
19.5
ml/min/173m2
65.3
65.2
0.12
3063
31549
(3016018) Differential panel - Cerebral spinal fluid
76
258
2.53
12.40
1.3
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
218
3053
0.60
12.38
1.4
1.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
259
1368
1.64
12.26
3.8
4.5
kpa
7.8
8.2
2.67
244
1324
(3022145) Colonoscopy Study observation
355
4447
0.67
12.18
1.2
1.3
—
—
—
0
0
(3010421) pH of Blood
285
1552
1.59
11.92
3.7
4.3
ph
7.4
7.4
0.74
246
1323
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
81
289
2.41
11.92
1.4
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
157
2370
0.56
11.86
1.5
2.3
g/l
3.0
3.2
0.90
86
1808
(3003458) Phosphate [Moles/volume] in Serum or Plasma
665
7445
0.74
11.81
3.5
4.8
mmol/l
1.0
1.1
0.55
530
6706
(3004789) Transferrin [Mass/volume] in Serum or Plasma
808
8800
0.76
11.80
2.1
2.5
g/l
2.2
2.2
1.68
616
7983
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
199
2772
0.60
11.07
2.5
3.4
mmol/l
24.0
24.1
0.11
161
2469
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
175
2512
0.59
10.98
2.1
2.5
u/ml
0.4
0.3
0.32
100
1473
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3840
30148
1.18
10.81
3.8
4.0
pmol/l
15.6
15.3
9.69
3079
26197
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3412
26554
1.18
10.62
4.6
6.4
mmol/l
1.2
1.2
5.24
2430
22000
(4010399)
228
3045
0.63
10.61
1.3
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
143
2144
0.56
10.57
1.7
2.4
g/l
1.9
1.3
0.42
89
1762
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
67
1283
0.44
10.47
1.6
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
701
0.25
10.42
1.5
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4169
38226
0.85
10.36
6.6
7.0
mmol/mol
43.5
41.7
16.02
3286
34001
(3000991) Gas panel - Venous blood
413
4880
0.71
10.28
3.3
6.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
3680
28863
1.17
10.27
4.6
4.7
mmol/l
7.2
7.0
9.16
3431
27148
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
330
1925
1.49
10.14
1.6
1.4
%
1.6
1.7
1.90
252
1544
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2921
22511
1.18
10.08
2.3
2.2
pmol/l
89.5
92.2
2.25
1453
11474
(3000494) Fungus identified in Specimen by Culture
384
4575
0.70
10.03
1.3
1.4
—
—
—
0
0
(3036489) Thrombin time
79
1398
0.48
9.97
1.7
1.7
s
20.8
22.2
0.80
66
1281
(3044242) Glucose [Moles/volume] in Arterial blood
83
325
2.20
9.94
1.4
1.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
134
2010
0.56
9.94
1.5
2.2
g/l
36.4
36.5
0.04
76
1641
(40768443) Skin Pathology biopsy report
153
2209
0.58
9.85
1.2
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
434
2683
1.41
9.80
1.6
1.8
ug/l
3.2
2.3
0.55
308
2266
(3019832) Treponema pallidum Ab [Presence] in Serum
132
618
1.84
9.65
1.0
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
116
1796
0.55
9.63
2.4
3.9
u/ml
269.0
91.4
1.25
106
1702
(3012095) Magnesium [Moles/volume] in Serum or Plasma
782
8333
0.78
9.51
2.1
2.6
mmol/l
0.8
0.8
1.04
639
7560
(3009445) Proteinase 3 Ab [Units/volume] in Serum
147
2114
0.59
9.33
1.2
1.5
—
20.3
—
0
49
(36304419) Bacteria [Presence] in Urine
1428
14229
0.83
9.30
3.3
3.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
417
2592
1.40
9.14
2.0
2.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
58
1108
0.44
9.07
3.1
2.4
—
—
—
0
0
(4094501)
44
938
0.40
9.04
1.1
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
270
3344
0.68
8.75
1.6
1.6
g/l
1.6
1.5
0.67
178
2826
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
87
1425
0.52
8.74
1.6
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
388
2402
1.40
8.72
2.0
1.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1980
14920
1.18
8.68
2.2
2.5
u/l
58.5
60.6
0.72
1727
13595
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2033
15376
1.18
8.49
2.3
2.4
mg/l
3.5
3.2
4.53
1528
12897
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
29
725
0.34
8.48
2.8
3.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1597
15632
0.84
8.40
2.3
2.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
344
0.20
8.33
1.1
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
344
0.20
8.33
1.1
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
40
848
0.40
8.15
1.2
1.2
u/ml
4.0
5.5
—
5
142
(3017446) Testosterone [Moles/volume] in Serum or Plasma
162
2185
0.63
7.94
1.5
2.0
nmol/l
8.6
9.9
1.17
127
1792
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
102
1546
0.56
7.93
1.3
1.6
u/l
35.8
38.1
0.41
72
1271
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
444
0.19
7.91
1.3
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
140
1944
0.61
7.78
2.3
2.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
34
756
0.38
7.76
1.1
1.2
—
0.8
—
0
8
(3022948) Iron [Moles/volume] in Serum or Plasma
922
9431
0.81
7.68
2.1
2.5
umol/l
10.6
11.3
1.90
701
8550
(3028026) IgM [Mass/volume] in Serum or Plasma
171
2260
0.64
7.67
1.8
1.8
g/l
1.7
1.5
0.20
121
1976
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
40
127
2.70
7.59
3.0
2.7
umol/l
26.0
29.9
1.44
31
94
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
82
1304
0.53
7.54
1.1
1.1
u/ml
1.0
1.0
—
6
18
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
655
6933
0.79
7.45
1.2
1.2
u/ml
1.6
1.7
0.09
211
1606
(3018677) aPTT in Platelet poor plasma by Coagulation assay
818
8423
0.81
7.24
1.5
1.9
s
29.9
30.5
1.53
771
8149
(3048689) Calprotectin [Mass/mass] in Stool
312
3636
0.72
7.17
1.6
1.8
ug/g
189.1
174.3
0.26
196
2729
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4571
36945
1.14
7.13
4.7
5.0
mu/l
2.1
2.2
1.24
3711
32333
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
21
46
3.91
7.13
1.0
1.1
%
14.8
60.6
—
8
18
(3005719) IgG [Mass/volume] in Serum or Plasma
227
2785
0.69
7.05
2.6
2.6
g/l
11.5
10.8
0.73
179
2496
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
61
247
2.12
6.85
1.0
1.1
—
2.3
—
0
7
(3052851) Hemolysis interference index of Serum or Plasma
130
1777
0.62
6.81
3.6
3.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
1280
9474
1.19
6.74
31.9
34.1
inr
1.5
1.6
0.25
116
1223
(3019977) pH of Arterial blood
86
398
1.86
6.66
1.6
2.2
ph
7.4
7.4
0.43
17
166
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
28
79
3.04
6.58
2.3
2.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
114
1593
0.61
6.57
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
282
3287
0.72
6.51
2.6
2.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
172
2188
0.66
6.48
2.6
2.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
239
0.18
6.26
1.0
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
119
1621
0.62
6.18
1.8
1.5
titre
97.1
285.7
2.25
14
78
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
60
974
0.52
5.99
1.4
1.6
mg/l
12.5
12.8
0.09
45
875
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
27
79
2.93
5.99
2.3
2.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
335
2160
1.34
5.94
1.3
1.3
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
16
33
4.15
5.88
1.7
2.8
nmol/l
124.2
133.4
0.18
11
27
(3021960) Folate [Moles/volume] in Serum or Plasma
1808
13877
1.15
5.88
1.6
1.6
nmol/l
20.2
20.0
0.09
1455
11565
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
22
521
0.36
5.88
1.4
1.5
mg/l
3.7
3.2
0.14
16
407
(3000330) Specific gravity of Urine by Test strip
273
3141
0.73
5.83
5.2
4.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
359
0.24
5.79
1.3
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
31
627
0.42
5.77
1.4
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
291
0.26
5.77
1.4
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
50
843
0.50
5.65
1.2
1.3
—
—
—
0
0
(4268621)
5
225
0.19
5.64
1.6
2.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
586
4093
1.24
5.60
3.1
4.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
36
675
0.45
5.53
1.4
1.2
—
—
—
0
0
(4027681)
27
83
2.79
5.52
1.1
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
223
2623
0.72
5.49
1.3
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
713
7246
0.82
5.49
1.7
1.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
975
9627
0.85
5.43
1.5
1.6
mg/l
2.1
1.7
1.40
721
7544
(3002179) Metamyelocytes/100 leukocytes in Blood
328
3635
0.76
5.41
3.0
3.5
%
0.6
0.6
0.05
65
893
(3042111) Morphology [Interpretation] in Bone marrow Narrative
66
1007
0.56
5.39
1.5
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1094
8140
1.17
5.35
3.4
4.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
41
158
2.22
5.28
1.6
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4414
39501
0.90
5.25
4.5
5.4
mmol/l
6.2
6.2
2.11
3395
34298
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
6
231
0.22
5.24
1.2
1.1
%
91.8
90.7
—
6
211
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
70
1040
0.57
5.21
1.7
1.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
21
478
0.37
5.19
1.1
1.5
g/l
0.9
0.8
0.03
14
356
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
69
1027
0.57
5.17
1.2
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
217
2534
0.72
5.13
1.3
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
98
511
1.65
5.13
1.3
1.2
nmol/l
293.0
308.6
0.27
62
369
(3007566) Smooth muscle Ab [Titer] in Serum
50
815
0.52
5.13
1.1
1.1
titre
80.0
82.8
—
6
43
(3045142) Bone marrow Pathology biopsy report
27
548
0.42
5.12
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
227
1414
1.38
5.07
3.3
3.8
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
23
495
0.40
5.02
1.1
1.3
mu/l
41.9
47.8
0.08
18
428
(3017181) Myelocytes/100 leukocytes in Blood
376
4052
0.78
5.00
3.2
3.6
%
1.1
1.0
0.25
107
1293
(3021440) Promyelocytes/100 leukocytes in Blood
356
3862
0.78
5.00
3.2
3.6
%
0.2
0.1
0.54
97
1210
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
47
196
2.06
5.00
1.0
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
213
1317
1.39
4.98
2.5
2.7
%
15.8
15.4
0.61
81
713
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
612
4358
1.22
4.89
1.5
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
17
413
0.35
4.87
1.1
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
25
508
0.42
4.78
1.6
1.2
—
18.9
—
0
7
(3024928) Oxygen saturation in Venous blood
82
1140
0.61
4.74
1.6
2.2
—
—
—
0
0
(1002224) Polysomnography panel
24
491
0.42
4.67
1.1
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
295
1944
1.31
4.58
1.8
2.1
ug/l
760.2
550.5
0.41
264
1842
(3034770) Mitochondria Ab [Titer] in Serum
54
827
0.55
4.54
1.1
1.1
—
1147.9
—
0
24
(3000850) Epithelial cells [#/volume] in Urine
1519
11707
1.14
4.52
3.0
2.8
e6/l
6.2
5.0
2.56
1382
10254
(3008898) HLA-B27 [Presence]
24
484
0.42
4.52
1.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
61
902
0.57
4.52
1.4
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
89
1198
0.63
4.50
1.3
1.5
g/l
29.0
30.4
0.52
74
1051
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
13
340
0.33
4.36
1.0
1.2
—
47.9
—
0
28
(40768800) Prostate Pathology biopsy report
82
1114
0.63
4.33
1.1
1.2
—
—
—
0
0
(3019225) pH of Specimen
759
5579
1.18
4.31
4.4
4.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
74
1027
0.61
4.29
1.5
1.5
iu/ml
0.8
11.0
1.20
17
278
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
322
0.32
4.25
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
247
0.31
4.25
1.0
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
77
1056
0.62
4.25
1.3
1.5
e6/l
1328.0
1821.3
0.72
61
776
(3052592) Norovirus Ag [Presence] in Stool
32
123
2.23
4.21
1.5
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
40
653
0.52
4.20
3.7
3.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
14
344
0.35
4.16
1.0
1.4
%
10.6
10.2
0.10
14
344
(3023183) Ammonium ion [Moles/volume] in Plasma
141
841
1.44
4.11
1.7
1.9
umol/l
27.8
33.4
1.52
109
656
(3005322) IgE [Units/volume] in Serum or Plasma
129
1578
0.69
4.09
1.2
1.2
u/ml
330.7
225.5
0.82
114
1422
(3045788) Cell count panel - Pleural fluid
55
811
0.58
4.07
1.4
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
25
474
0.45
4.06
1.1
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
65
917
0.60
4.05
1.4
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
529
5367
0.83
4.02
1.8
2.4
g/l
65.0
65.8
1.03
399
4706
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
26
483
0.46
4.01
1.3
1.3
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
15
349
0.37
3.99
1.0
1.2
—
77.5
—
0
14
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
10
284
0.30
3.97
1.1
1.7
pmol/l
158.7
184.4
—
10
254
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
79
1054
0.64
3.89
1.4
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
40
633
0.54
3.83
3.6
3.5
%
53.3
61.2
0.57
18
376
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
30
520
0.49
3.82
1.5
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
25
461
0.46
3.80
1.1
1.3
pmol/l
213.9
240.7
0.29
20
352
(3028308) Erythrocytes [#/volume] in Pleural fluid
71
964
0.63
3.79
1.3
1.5
e6/l
55474.7
56477.4
0.01
43
579
(3039162) Centromere protein B Ab [Units/volume] in Serum
18
376
0.41
3.76
1.2
1.2
—
47.6
—
0
25
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
23
435
0.45
3.75
1.7
1.3
u/ml
116.3
125.3
—
7
88
(3025159) Blasts/100 leukocytes in Blood
337
3546
0.80
3.71
3.2
3.6
%
0.0
0.2
1.34
84
994
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
929
7023
1.15
3.68
1.7
1.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
75
998
0.64
3.67
1.2
1.4
g/l
1.2
1.1
0.61
65
932
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
73
975
0.64
3.64
1.2
1.4
g/l
0.2
0.2
0.23
64
909
(3021788) Differential panel - Synovial fluid
69
932
0.63
3.62
1.6
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
23
428
0.46
3.60
1.2
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
33
138
2.05
3.58
1.1
1.1
mg/l
37.7
49.0
1.10
26
113
(3036782) Glucose [Moles/volume] in Pleural fluid
54
765
0.60
3.48
1.2
1.4
mmol/l
6.4
6.5
0.15
43
713
(3035637) Corticotropin [Mass/volume] in Plasma
22
409
0.46
3.45
1.0
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
27
466
0.49
3.43
1.3
1.3
nmol/l
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
25
95
2.25
3.43
1.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
1981
15726
1.10
3.40
3.0
3.9
ph
7.4
7.4
0.70
514
2975
(3048929) Epstein Barr virus Ab [Presence] in Serum
33
532
0.53
3.40
1.1
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
23
85
2.32
3.36
3.3
2.5
u/field
0.3
0.4
0.70
23
85
(3047181) Lactate [Moles/volume] in Blood
144
1664
0.73
3.32
3.9
5.4
mmol/l
1.4
1.4
0.10
128
1477
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
13
294
0.38
3.31
1.1
1.2
—
112.3
—
0
13
(3015171) Extractable nuclear Ab [Units/volume] in Serum
97
1196
0.69
3.29
1.3
1.2
u/ml
0.2
0.8
1.83
12
126
(3023419) Bacteria identified in Sputum by Culture
53
742
0.61
3.28
1.6
2.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
161
0.26
3.27
1.0
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
449
4526
0.84
3.22
2.6
3.5
ng/l
88.5
102.8
2.37
286
3729
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
25
432
0.49
3.22
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
202
0.34
3.20
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
202
0.34
3.20
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
202
0.34
3.20
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
202
0.34
3.20
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
202
0.34
3.20
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
202
0.34
3.20
1.4
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
46
661
0.59
3.17
3.0
3.6
iu/ml
169.2
3182.8
—
5
91
(3034426) Prothrombin time (PT)
0
73
0.00
3.13
0.0
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
30
128
2.01
3.12
1.0
1.0
mg/l
278.5
327.8
0.78
23
111
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
31
134
1.98
3.11
1.2
1.4
umol/l
101.4
79.9
0.24
16
80
(3005570) Glucose [Moles/volume] in Urine
103
614
1.44
3.10
2.5
2.1
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
13
37
3.01
3.10
1.0
1.2
pmol/l
23.4
12.6
0.67
13
31
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
86
495
1.49
3.10
1.3
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
37
171
1.85
3.07
1.1
1.1
promille
1.1
1.0
0.16
22
126
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
183
2014
0.77
3.01
2.3
2.5
au/ml
43.5
24.5
—
5
39
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
11
29
3.25
2.95
1.1
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
50
690
0.62
2.95
1.3
1.1
—
—
—
0
0
(4024509)
39
572
0.58
2.94
1.6
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
13
277
0.40
2.93
1.0
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
61
802
0.65
2.91
1.3
1.3
u/l
304.1
366.5
0.40
52
759
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
56
750
0.64
2.91
1.2
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
34
3.02
2.89
1.8
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
118
732
1.38
2.87
1.3
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
213
2285
0.79
2.86
2.0
2.8
mg/l
48.5
94.2
1.13
155
1869
(3009214) Lutropin [Units/volume] in Serum or Plasma
21
368
0.49
2.85
1.3
1.3
u/l
18.0
12.4
0.74
14
280
(40757373) Influenza virus identified in Isolate
29
127
1.96
2.84
1.4
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
239
2524
0.80
2.80
3.3
4.4
%
0.9
0.9
0.04
228
2388
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
28
444
0.54
2.80
1.1
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
213
2278
0.79
2.80
2.0
2.8
mg/l
69.5
57.3
0.17
157
1866
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
0
65
0.00
2.79
0.0
1.1
—
6.8
—
0
51
(3045424) Erythrocytes [Presence] in Urine
52
699
0.63
2.76
1.7
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
35
165
1.82
2.76
1.2
1.2
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
10
232
0.37
2.75
4.6
1.7
%
70.7
69.4
—
10
214
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
75
933
0.68
2.74
1.2
1.2
u/l
25.7
44.0
1.95
55
788
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
146
0.29
2.71
1.6
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
404
0.53
2.67
1.1
1.1
u/ml
358.5
320.3
0.24
17
230
(3013166) Neutrophils/100 leukocytes in Synovial fluid
34
161
1.81
2.66
1.3
1.3
%
78.6
63.6
3.19
23
139
(3044941) Cell count panel - Synovial fluid
63
804
0.67
2.64
1.5
1.4
—
—
—
0
0
(4281824)
30
457
0.56
2.63
1.2
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
106
1233
0.73
2.63
1.7
1.6
e6/l
31976.7
15451.8
0.96
84
877
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
209
2219
0.80
2.60
2.0
2.8
ratio
3.9
3.0
0.24
21
156
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
297
0.46
2.59
1.2
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
225
0.38
2.59
4.6
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
17
308
0.47
2.57
1.0
1.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
522
5099
0.87
2.57
2.9
5.2
mmol/l
1.6
1.4
2.58
486
4829
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
26
114
1.95
2.56
2.3
2.0
umol/l
56.0
51.5
0.27
17
83
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
45
612
0.63
2.55
1.1
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
244
2541
0.81
2.54
3.5
4.4
%
1.5
1.5
0.18
232
2407
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
32
473
0.58
2.53
1.0
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
164
1785
0.78
2.53
1.3
1.3
au/ml
47.7
61.6
—
9
69
(4306422)
16
294
0.46
2.52
1.2
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
609
5876
0.88
2.51
3.9
4.8
%
34.3
34.4
0.03
273
3677
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
10
28
3.06
2.46
1.1
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
33
2.85
2.43
1.5
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
20
335
0.51
2.43
1.6
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
282
2881
0.83
2.42
1.3
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
67
388
1.48
2.42
1.7
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
62
778
0.68
2.41
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
265
2719
0.83
2.39
2.7
2.9
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
59
335
1.51
2.35
2.6
1.9
u/field
2.2
2.6
0.18
43
214
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
27
124
1.86
2.35
1.1
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
35
493
0.61
2.32
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
43
576
0.64
2.31
1.1
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
22
95
1.98
2.28
1.1
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
145
1579
0.78
2.28
1.1
1.1
iu/ml
69.3
126.5
1.47
56
510
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2063
18629
0.93
2.26
2.6
3.0
ug/l
158.0
159.5
0.07
1621
16523
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
48
624
0.66
2.25
1.3
1.3
u/l
21.3
12.3
0.51
40
568
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
13
245
0.45
2.23
1.7
2.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
909
7085
1.11
2.23
1.7
1.8
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
26
389
0.57
2.20
1.5
1.6
mg/l
5.2
5.2
0.01
19
365
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
30
431
0.59
2.18
1.1
1.1
u/ml
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
35
483
0.62
2.16
1.0
1.1
u/l
52.1
61.9
0.47
18
314
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
75
456
1.41
2.14
1.3
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
129
855
1.29
2.11
2.3
3.3
%
62.1
60.4
0.67
129
855
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
20
86
1.99
2.11
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
20
86
1.99
2.11
1.1
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
106
1186
0.76
2.08
4.2
5.9
mmol/l
11.3
11.4
0.09
96
1066
(3018572) Chloride [Moles/volume] in Blood
106
1186
0.76
2.08
4.2
5.9
mmol/l
104.8
104.6
0.11
96
1066
(3003327) Ova and parasites identified in Stool by Light microscopy
79
922
0.73
2.07
1.6
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
8
166
0.41
2.06
1.5
1.1
—
0.9
—
0
56
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
166
0.41
2.06
1.6
2.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
622
5911
0.89
2.05
2.7
3.5
mmol/l
2.2
1.9
1.23
492
4705
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
151
0.40
2.05
1.1
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
212
0.44
2.03
1.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
19
82
1.98
2.00
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
73
448
1.40
2.00
1.3
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
129
1396
0.79
1.97
1.4
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
316
3134
0.86
1.97
4.1
5.7
mmol/l
24.5
24.8
0.85
304
3091
(44816559) Phosphatidylethanol [Mass/volume] in Blood
26
376
0.59
1.97
1.2
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
208
0.45
1.94
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
51
633
0.69
1.94
1.3
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3893
34281
0.94
1.94
19.0
22.0
%
35.5
36.8
4.66
1342
19216
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
102
1132
0.77
1.92
1.5
2.7
u/ml
217.6
959.0
1.68
83
1025
(3038177) Helicobacter pylori Ab [Presence] in Serum
32
436
0.63
1.91
1.4
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
82
519
1.35
1.88
1.2
1.3
mosm/kgh2o
274.4
274.0
0.05
60
360
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
239
0.50
1.87
1.0
1.0
—
—
—
0
0
(4015189)
9
169
0.45
1.85
1.6
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
130
1393
0.79
1.85
1.0
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
627
5917
0.90
1.84
2.7
3.5
kpa
5.9
5.8
1.03
597
5700
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
94
610
1.32
1.84
1.3
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2498
20451
1.07
1.83
3.3
3.4
ng/l
2219.5
2349.6
0.60
1964
17890
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
20
302
0.56
1.80
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
172
1206
1.22
1.80
1.2
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
200
1424
1.21
1.80
2.2
2.4
g/l
123.6
124.1
0.09
181
1049
(3036481) Cortisol [Moles/volume] in Serum or Plasma
464
3529
1.13
1.79
1.6
2.0
nmol/l
393.1
386.5
0.28
369
3153
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
19
86
1.89
1.78
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
119
0.36
1.76
1.2
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
19
288
0.56
1.74
1.1
1.3
g/l
6.5
7.0
0.19
11
210
(3024139) IgG subclass 3 [Mass/volume] in Serum
19
288
0.56
1.74
1.1
1.3
g/l
0.5
0.5
0.04
11
212
(3028192) IgG subclass 2 [Mass/volume] in Serum
19
288
0.56
1.74
1.1
1.3
g/l
2.6
2.8
0.19
11
214
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
31
164
1.62
1.74
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
63
737
0.73
1.73
1.1
1.1
—
21.9
—
0
24
(3032773) Endomysium IgG Ab [Titer] in Serum
45
260
1.48
1.73
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
0
40
0.00
1.72
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
41
0.00
1.72
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
153
0.45
1.71
1.1
1.2
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
461
3521
1.13
1.68
3.5
6.9
%
0.8
0.7
11.42
455
3490
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
88
1.85
1.67
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
89
583
1.31
1.66
2.6
2.9
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
375
2830
1.14
1.66
2.2
2.5
%
0.7
0.7
4.50
358
2729
(3014765) Yersinia sp identified in Stool by Organism specific culture
172
1219
1.21
1.65
1.2
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
24
336
0.61
1.64
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
30
160
1.60
1.64
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
172
1220
1.21
1.64
1.2
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
29
154
1.61
1.62
1.1
1.0
nmol/l
115.1
137.6
1.97
29
154
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
28
376
0.64
1.61
2.8
3.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
59
2.03
1.60
1.2
1.1
miu/ml
1979.0
1537.0
0.53
14
59
(4062490)
20
290
0.59
1.58
1.3
1.3
—
—
—
0
0
(4198724)
5
12
3.56
1.58
1.4
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
20
289
0.59
1.57
1.4
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
48
2.14
1.56
1.5
1.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
7
137
0.44
1.55
5.1
1.7
%
4.4
8.7
—
7
128
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
19
277
0.59
1.54
1.3
1.5
u/l
3.0
6.7
—
7
117
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
36
0.00
1.54
0.0
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
37
0.00
1.54
0.0
1.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
37
0.00
1.54
0.0
1.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
429
3284
1.12
1.53
2.7
3.5
mmol/l
25.3
25.0
1.13
419
3186
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
25
130
1.65
1.52
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
37
461
0.68
1.50
1.2
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
49
2.09
1.49
1.5
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4200
35049
1.05
1.48
5.0
7.4
u/l
83.9
84.6
0.22
3586
32568
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
184
1329
1.19
1.47
1.9
2.3
ug/min
82.0
85.6
0.04
77
758
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
426
4048
0.89
1.47
1.8
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
2831
23387
1.05
1.47
12.0
12.6
inr
1.3
1.4
6.98
880
6191
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
115
793
1.24
1.46
1.8
2.2
mg/l
34.4
29.0
0.35
28
178
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
44
2.14
1.43
1.5
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
28
364
0.66
1.42
1.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
25
333
0.64
1.42
3.4
3.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
30
384
0.67
1.42
1.1
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
96
1026
0.80
1.41
4.1
3.6
%
1.7
1.4
0.26
66
764
(3035320) C reactive protein [Mass/volume] in Body fluid
26
341
0.65
1.38
3.0
2.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
10
39
2.19
1.38
1.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1022
9298
0.93
1.37
3.4
3.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
23
309
0.64
1.37
1.1
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
8
139
0.49
1.37
1.0
1.0
—
1.3
—
0
51
(3042631) Mycobacterium sp identified in Specimen
89
955
0.79
1.36
2.3
2.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
103
1087
0.81
1.36
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
51
2.01
1.36
1.5
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
51
2.01
1.36
1.5
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
33
0.00
1.35
0.0
1.1
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
33
0.00
1.35
0.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
35
0.00
1.33
0.0
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
128
0.47
1.32
5.1
1.7
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
7
129
0.46
1.32
1.3
1.5
ug/l
11.7
287.2
—
7
120
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
6
20
2.57
1.32
1.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
113
0.45
1.29
1.0
1.4
umol/l
29.7
29.9
—
6
107
(3013512) EKG study
1896
15547
1.06
1.28
4.7
4.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
27
344
0.67
1.27
1.1
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
37
444
0.71
1.27
2.2
3.2
mg/l
56.1
36.9
0.39
27
337
(21491868) Cryoglobulin [Mass/volume] in Serum
8
135
0.51
1.26
1.1
1.2
g/l
—
0.3
—
0
9
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
164
0.52
1.26
3.0
1.9
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
8
136
0.50
1.25
4.0
5.6
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
102
0.42
1.25
1.2
1.4
ng/l
96.6
134.5
—
5
102
(3008401) Mugwort IgE Ab [Units/volume] in Serum
8
137
0.50
1.25
1.0
1.0
—
1.8
—
0
51
(40760888) Immunoglobulin light chains.free panel - Serum
172
1714
0.85
1.25
2.1
2.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
136
1381
0.84
1.24
1.3
1.4
ug/g
250.3
261.1
0.26
70
860
(3037556) Urate [Mass/volume] in Serum or Plasma
10
163
0.52
1.24
2.0
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
744
6818
0.93
1.23
3.5
5.6
kpa
4.9
5.0
3.40
698
6396
(3027801) Oxygen [Partial pressure] in Arterial blood
744
6815
0.93
1.21
3.5
5.6
kpa
11.0
11.5
1.79
698
6391
(44806071)
5
16
2.67
1.21
1.2
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
41
253
1.39
1.19
1.0
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
484
4510
0.91
1.19
1.8
2.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
48
305
1.35
1.18
1.2
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
48
305
1.35
1.18
1.2
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
29
0.00
1.17
0.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
36
427
0.72
1.17
1.1
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
30
0.00
1.16
0.0
1.3
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
31
0.00
1.15
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
31
0.00
1.15
0.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
17
2.51
1.14
1.6
1.5
umol/l
20.3
15.2
—
5
17
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
10
158
0.54
1.13
1.4
1.7
e6/l
830.0
21534.8
—
5
94
(3043410) Blood group antigens tested for on Red Blood Cells
11
168
0.56
1.12
1.5
2.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
41
472
0.74
1.11
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
180
1335
1.16
1.11
1.2
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
73
497
1.26
1.10
1.2
1.4
titre
199.2
316.5
0.36
12
52
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
117
0.51
1.10
5.1
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
177
0.58
1.08
1.1
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
85
591
1.23
1.08
1.7
1.6
u/ml
31.0
26.8
0.34
25
131
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
36
420
0.73
1.08
1.1
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
15
208
0.62
1.07
1.0
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
15
208
0.62
1.07
1.0
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
50
1.88
1.07
1.5
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
21
269
0.67
1.05
1.0
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
21
269
0.67
1.05
1.0
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
21
269
0.67
1.05
1.0
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
130
0.53
1.03
1.1
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
12
57
1.80
1.03
1.8
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
171
1673
0.87
1.02
2.1
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
163
0.58
1.02
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
163
0.58
1.02
1.0
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1853
16410
0.95
1.01
3.6
3.6
e6/l
178.9
135.7
0.29
1560
12843
(3046861) Legionella sp Ag [Presence] in Urine
7
30
2.00
0.99
1.1
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
46
300
1.31
0.99
1.6
2.1
umol/l
19.0
22.3
—
9
32
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
71
1.69
0.99
1.2
1.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
26
0.00
0.98
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
26
0.00
0.98
0.0
1.8
—
1.3
—
0
26
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
27
0.00
0.97
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
16
212
0.64
0.96
1.3
1.4
—
—
—
0
0
(44790049)
41
459
0.76
0.95
1.2
1.3
—
—
—
0
0
(44790048)
41
459
0.76
0.95
1.2
1.3
—
—
—
0
0
(44806118)
41
459
0.76
0.95
1.2
1.3
—
—
—
0
0
(44790047)
41
459
0.76
0.95
1.2
1.3
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
6
101
0.51
0.95
7.7
3.2
—
32.4
—
0
9
(3027456) Digoxin [Moles/volume] in Serum or Plasma
269
2078
1.11
0.92
3.7
3.2
nmol/l
0.8
0.8
0.21
189
1583
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
66
693
0.81
0.92
4.6
5.5
mg/l
13.6
12.8
0.55
53
619
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
59
626
0.80
0.90
1.4
1.4
%
78.0
64.6
2.76
40
404
(40768446) Kidney Pathology biopsy report
5
87
0.49
0.90
1.0
1.5
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
5
89
0.48
0.90
1.0
1.0
—
2.1
—
0
10
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
83
849
0.83
0.89
1.3
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
22
268
0.70
0.89
1.0
1.3
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
21
122
1.47
0.88
1.3
1.5
pmol/l
19.0
16.5
0.73
11
91
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
30
346
0.74
0.87
1.0
1.1
—
12.6
—
0
7
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
39
1.75
0.83
1.0
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
58
401
1.24
0.82
1.1
1.1
mmol/l
31.1
35.2
0.90
44
328
(4211845)
24
283
0.72
0.82
4.7
4.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
22
263
0.71
0.81
4.9
4.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
21
0.00
0.80
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
21
0.00
0.80
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
21
0.00
0.80
0.0
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2894
25283
0.97
0.80
3.6
5.6
umol/l
12.5
12.9
0.56
2503
23843
(40761539) Cells [Type] in Urine sediment by Light microscopy
25
154
1.39
0.80
1.2
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
68
481
1.21
0.79
1.2
1.4
titre
58.3
56.6
—
6
38
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
23
0.00
0.78
0.0
2.0
—
4.2
—
0
5
(40758358) Immune stain study
0
23
0.00
0.78
0.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
84
0.51
0.78
6.0
8.7
—
—
—
0
0
(3024316) Viscosity of Plasma
0
24
0.00
0.77
0.0
1.9
—
1.7
—
0
15
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
24
0.00
0.77
0.0
1.3
—
0.1
—
0
16
(3007853) Bacteria identified in Skin by Aerobe culture
705
5715
1.06
0.77
1.7
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1604
14157
0.96
0.76
4.4
5.1
%
20.8
22.7
6.44
846
7872
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
45
1.71
0.76
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
77
778
0.84
0.76
1.2
1.3
—
—
—
0
0
(44806420)
21
248
0.72
0.74
2.2
2.4
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
21
2.04
0.73
1.2
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
92
0.56
0.73
1.3
2.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
75
752
0.85
0.69
1.6
1.5
iu/l
2.7
4.3
2.08
22
196
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
41
436
0.80
0.69
1.1
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
23
144
1.37
0.69
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
155
0.66
0.68
1.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
15
185
0.69
0.68
1.1
1.1
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
30
331
0.77
0.68
1.3
1.6
%
50.7
68.4
1.21
18
264
(3028717) Thiamine [Mass/volume] in Blood
5
23
1.86
0.68
1.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
102
0.59
0.68
1.3
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
419
3357
1.07
0.68
3.8
3.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
43
453
0.81
0.67
1.1
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
64
647
0.84
0.66
1.1
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
19
116
1.40
0.66
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
183
0.70
0.65
1.0
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
949
7796
1.05
0.65
2.3
2.2
%
1.8
1.8
0.17
686
6731
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
398
3624
0.94
0.64
2.7
3.0
ml/min/173m2
57.5
54.6
0.97
169
1771
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
64
645
0.85
0.64
1.1
1.3
—
—
—
0
0
(3016750) Collection duration of Urine
31
337
0.79
0.64
2.1
2.0
min
535.1
499.4
1.25
17
237
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
166
1568
0.90
0.64
1.6
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
182
0.70
0.64
1.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
11
142
0.66
0.64
1.4
2.9
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
22
250
0.75
0.63
1.3
1.3
ug/l
1030.7
146.0
0.45
14
135
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
12
67
1.53
0.63
2.8
4.9
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
25
1.71
0.63
1.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
25
1.71
0.63
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
39
410
0.81
0.61
8.6
14.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
161
1518
0.90
0.61
2.5
3.0
kpa
7.3
7.7
2.65
150
1403
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
17
0.00
0.61
0.0
1.3
—
298.5
—
0
17
(44813793)
13
160
0.69
0.60
1.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
42
437
0.82
0.60
1.1
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
42
437
0.82
0.60
1.1
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
42
437
0.82
0.60
1.1
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
31
333
0.79
0.59
1.7
1.9
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
20
0.00
0.59
0.0
1.4
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
20
0.00
0.59
0.0
9.8
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
16
188
0.73
0.58
1.0
1.0
mg/l
278.8
294.9
—
10
163
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
42
295
1.22
0.57
4.7
3.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
48
342
1.20
0.57
1.1
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
65
645
0.86
0.56
1.1
1.3
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
173
1615
0.91
0.55
3.5
3.8
mmol/l
8.4
7.7
1.95
173
1582
(3013707) Erythrocyte sedimentation rate by Westergren method
3804
32084
1.03
0.55
3.6
4.4
mm/h
17.0
16.8
0.31
3126
28909
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
119
913
1.12
0.54
1.3
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
2103
18356
0.97
0.54
4.1
4.1
e6/l
237.2
151.3
1.26
1650
13609
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
65
641
0.87
0.53
1.1
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
60
595
0.86
0.52
1.1
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
21
232
0.77
0.52
1.0
1.5
mg/l
47.3
71.4
—
10
153
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
22
241
0.78
0.51
1.0
1.1
u/l
70.8
32.0
0.73
13
177
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
22
241
0.78
0.51
1.0
1.1
u/l
127.6
94.2
0.60
15
182
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
67
657
0.87
0.51
1.1
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
66
647
0.87
0.50
1.1
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
11
64
1.47
0.50
1.2
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
14
86
1.39
0.49
1.4
1.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
93
0.64
0.49
1.3
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
93
0.64
0.49
1.3
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
93
0.64
0.49
1.3
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
93
0.64
0.49
1.3
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
39
1.53
0.48
1.0
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
13
79
1.41
0.48
1.2
1.1
—
16.1
—
0
8
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
73
708
0.88
0.48
1.2
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
16
181
0.76
0.47
2.4
2.9
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
39
396
0.84
0.47
1.1
1.1
iu/ml
108.4
727.6
—
9
60
(3024891) Influenza virus A+B Ag [Presence] in Specimen
140
1095
1.09
0.47
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
73
0.59
0.45
1.4
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
66
1.43
0.44
1.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
81
620
1.12
0.42
2.7
2.4
u/field
2.4
2.1
0.23
45
193
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
13
0.00
0.41
0.0
1.9
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
13
0.00
0.41
0.0
1.1
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
13
0.00
0.41
0.0
2.2
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.41
0.0
2.0
—
16.7
—
0
14
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
14
0.00
0.41
0.0
1.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
14
0.00
0.41
0.0
1.5
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
14
0.00
0.41
0.0
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
28
197
1.22
0.41
1.2
1.3
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
12
138
0.74
0.41
1.0
1.2
mmol/l
1.4
1.4
—
6
84
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
29
1.47
0.40
1.0
1.1
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
16
0.00
0.40
0.0
1.1
—
17.7
—
0
8
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
16
0.00
0.40
0.0
2.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
94
884
0.91
0.39
2.9
2.7
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
18
121
1.27
0.38
1.3
1.4
%
26.2
18.3
—
10
92
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
82
633
1.11
0.38
1.5
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2039
17715
0.98
0.37
4.3
5.9
ug/l
4.7
6.0
0.96
1611
15420
(3044007) Cell count panel - Peritoneal fluid
12
135
0.76
0.36
1.5
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
776
6826
0.97
0.36
3.4
5.6
mmol/l
1.4
1.1
1.13
570
5211
(3026692) Albumin [Mass/volume] in Peritoneal fluid
19
130
1.25
0.36
1.4
1.2
g/l
10.4
15.6
1.72
13
101
(3003181) Sodium [Moles/volume] in Urine
150
1195
1.07
0.36
1.3
1.3
mmol/l
63.6
60.4
0.50
115
947
(3001893) Eosinophils/100 leukocytes in Pleural fluid
29
293
0.85
0.36
1.4
1.5
%
2.4
2.7
0.10
20
237
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
45
336
1.15
0.36
1.3
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
107
0.72
0.35
1.1
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
37
1.39
0.35
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
37
1.39
0.35
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
37
1.39
0.35
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
75
707
0.91
0.35
1.2
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
45
337
1.14
0.34
1.3
1.4
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
34
249
1.17
0.34
1.7
1.8
mmol/l
9.1
9.1
0.02
28
201
(3016502) Oxygen saturation in Arterial blood
727
6041
1.03
0.33
3.5
5.8
%
95.2
95.0
0.27
696
5781
(3015183) Erythrocyte sedimentation rate
6
77
0.67
0.33
1.0
1.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
609
5365
0.97
0.32
3.6
6.2
g/l
120.0
118.1
1.62
593
5178
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
10
63
1.36
0.32
1.5
1.0
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
821
7197
0.97
0.32
3.7
5.7
mmol/l
104.4
104.1
0.52
752
7022
(3028433) Virus identified in Specimen by Culture
12
132
0.78
0.32
1.1
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
61
470
1.11
0.31
1.4
1.4
%
11.6
26.8
10.17
42
302
(3017732) Neutrophils [#/volume] in Blood
308
2747
0.96
0.31
3.1
3.3
e9/l
4.6
4.4
0.44
152
1801
(3020650) Glucose [Presence] in Urine
7
83
0.72
0.31
3.9
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
1300
11320
0.98
0.30
3.3
3.0
mosm/kgh2o
555.9
534.9
3.52
1130
9573
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
46
1.30
0.30
1.0
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
36
351
0.88
0.30
1.8
2.0
ug/l
1.8
2.0
0.14
27
291
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4995
42434
1.02
0.30
8.4
11.4
u/l
21.8
22.7
0.81
4403
40197
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
8
53
1.29
0.28
1.0
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
664
5822
0.97
0.28
2.5
2.4
e9/l
65.6
66.7
0.34
515
4435
(3036670) Protein [Mass/volume] in Synovial fluid
19
194
0.84
0.28
1.2
1.1
g/l
41.3
39.3
0.47
12
91
(3011335) Digoxin [Mass/volume] in Serum or Plasma
9
100
0.77
0.27
3.6
2.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
9
102
0.75
0.27
1.1
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
63
0.68
0.26
1.0
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
224
2000
0.96
0.26
2.7
3.0
pmol/l
4.2
4.2
0.02
173
1684
(40762814) Titanium [Mass/volume] in Blood
14
97
1.23
0.25
2.2
2.0
ug/l
2.9
3.4
—
7
39
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
66
1.30
0.25
1.5
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
15
105
1.22
0.25
1.6
1.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
26
255
0.87
0.25
1.2
1.3
mmol/l
3.9
3.3
0.55
21
231
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
9
65
1.18
0.24
1.2
1.2
ug/l
1.3
1.4
—
9
59
(3003338) MCHC [Mass/volume]
3582
30845
0.99
0.24
25.8
27.2
g/l
329.6
329.7
0.53
3408
30383
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
25
186
1.15
0.23
1.2
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
52
407
1.09
0.22
1.3
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
35
1.22
0.22
1.0
1.0
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
9
0.00
0.21
0.0
1.8
—
2.8
—
0
9
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
9
0.00
0.21
0.0
1.3
—
4.3
—
0
9
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
73
669
0.93
0.21
1.2
1.3
nmol/l
1.0
0.8
0.73
55
530
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
16
115
1.19
0.21
1.6
2.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
6.8
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.2
—
1708.2
—
0
11
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
124
1114
0.95
0.20
2.4
2.4
mg/l
1.8
1.9
0.37
98
959
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
97
0.79
0.20
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
42
1.22
0.20
1.2
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
99
0.78
0.20
1.0
1.1
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
6
43
1.19
0.19
1.8
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
53
487
0.93
0.18
1.8
2.1
ml
692.0
611.1
0.44
21
302
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
443
3704
1.02
0.17
3.0
3.7
mmol/l
1.9
2.1
0.62
314
2716
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
148
1216
1.04
0.17
1.2
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
57
0.75
0.17
12.2
9.6
%
13.4
14.0
—
5
57
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
30
233
1.10
0.16
4.5
5.2
u/ml
125.3
58.8
—
7
68
(3020491) Glucose [Moles/volume] in Blood
37
343
0.92
0.16
1.9
2.6
mmol/l
7.6
7.3
0.41
24
222
(3022313) Gas panel - Capillary blood
312
2727
0.98
0.14
3.1
3.9
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
110
0.85
0.14
1.1
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
12
119
0.86
0.14
1.8
1.4
ug/l
9.2
9.8
0.09
12
104
(3024263) Appearance of Synovial fluid
30
279
0.92
0.14
1.6
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
525
4561
0.98
0.14
1.6
1.9
g/l
0.2
0.2
0.97
426
4143
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
86
0.79
0.13
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
183
1519
1.03
0.13
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
183
1519
1.03
0.13
1.4
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
577
4858
1.02
0.13
2.5
3.0
kpa
4.0
4.3
6.30
547
4658
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
12
89
1.15
0.12
1.1
1.1
—
—
—
0
0
(4146454)
72
590
1.04
0.11
2.5
2.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
81
719
0.96
0.10
1.2
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
204
1706
1.02
0.10
2.8
3.3
mmol/l
25.0
25.1
0.16
187
1488
(3009343) pH of Capillary blood
454
3828
1.01
0.10
3.0
3.8
ph
7.4
7.4
1.48
75
498
(3006576) Bicarbonate [Moles/volume] in Blood
25
198
1.08
0.10
3.2
5.8
mmol/l
24.5
24.6
0.01
20
180
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
14
107
1.12
0.09
1.2
1.1
u/l
1.0
1.2
—
8
65
(3014891) Appearance of Pleural fluid
17
159
0.91
0.09
1.6
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
48
1.07
0.08
1.0
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
459
3877
1.01
0.08
3.1
3.8
kpa
5.2
5.2
0.19
385
3532
(3020874) Milk IgE Ab [Units/volume] in Serum
5
53
0.81
0.08
1.0
1.1
—
0.4
—
0
20
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
55
1.09
0.08
1.0
1.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
25
228
0.94
0.08
1.1
1.4
%
2.6
3.7
—
10
54
(3044927) Protein electrophoresis panel - Urine
87
722
1.03
0.08
1.2
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
151
1316
0.98
0.07
2.5
2.9
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
7
71
0.84
0.07
1.1
1.6
umol/l
46.1
48.6
—
7
71
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
21
192
0.93
0.07
1.0
1.4
%
17.9
21.4
0.25
15
158
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
20
183
0.93
0.06
1.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
81
0.84
0.06
1.0
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
19
151
1.08
0.06
1.7
1.7
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
23
209
0.94
0.06
1.2
1.3
nmol/l
1.1
1.1
0.01
11
158
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
259
2242
0.99
0.06
3.5
4.3
mmol/l
24.9
24.8
0.19
200
2016
(1761482) Bacteria [#/volume] in Urine by Culture
226
1957
0.99
0.06
5.6
4.9
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
18
144
1.07
0.05
3.7
2.5
mmol/l
7.1
7.5
—
10
96
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
132
1147
0.98
0.05
1.3
1.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
124
1042
1.02
0.05
2.7
2.6
mmol/l
4.2
4.1
0.22
124
1034
(3035285) Chloride [Moles/volume] in Venous blood
124
1042
1.02
0.05
2.7
2.6
mmol/l
106.9
105.3
1.99
124
1034
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
15
119
1.08
0.05
1.1
1.3
%
27.2
28.0
—
9
81
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2630
22429
1.00
0.04
2.9
3.1
u/l
53.8
58.7
1.54
2132
19899
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
23
187
1.05
0.04
5.7
6.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
78
653
1.02
0.04
5.9
3.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
137
0.94
0.04
1.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
122
1029
1.01
0.03
2.7
2.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
225
1940
0.99
0.03
2.4
2.7
g/l
0.4
0.3
0.47
65
728
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
13
104
1.07
0.03
1.5
1.6
mmol/l
1.2
1.2
0.22
13
99
(3004451) EKG impression Narrative
41
342
1.02
0.02
1.2
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
60
504
1.02
0.02
1.4
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
20
164
1.04
0.02
1.6
1.7
ug/l
65.0
65.1
0.00
20
157
(3037756) Immunofixation for Serum or Plasma
170
1464
0.99
0.02
1.2
1.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
23
190
1.03
0.01
1.8
2.3
ml
1603.6
1771.9
0.24
14
150
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
110
1.01
0.00
1.1
1.1
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
12
101
1.02
0.00
1.2
1.1
—
26.5
—
0
10
(3002523) Influenza virus A Ag [Presence] in Specimen
16
137
1.00
0.00
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
102
1.01
0.00
1.1
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
67
577
0.99
0.00
1.2
1.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
11
94
1.00
0.00
1.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
23
199
0.99
0.00
1.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
39
333
1.00
0.00
1.7
1.8
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
19
161
1.01
0.00
1.0
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
42
357
1.01
0.00
1.2
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
25
211
1.01
0.00
1.1
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
439
3752
1.00
0.00
2.7
3.2
g/l
127.3
124.4
2.12
433
3657
(3010144) Erythrocytes [#/volume] in Synovial fluid
56
483
0.99
0.00
1.3
1.3
e6/l
210850.8
193457.8
0.05
39
331
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
44
0.97
0.00
1.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
0.2
—
0
8
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
342.2
—
0
5
(4212803)
7
68
0.88
0.00
1.1
1.0
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
74.2
—
0
6
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
45
0.95
0.00
1.0
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
42
1.02
0.00
1.0
1.2
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
19.0
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
1.6
—
0
6
(3043614) Bacteria identified in Aspirate by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
7
0.00
0.00
0.0
7.0
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
42
1.02
0.00
1.0
1.1
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030940) RBC casts [#/area] in Urine by Computer assisted method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
6
0.00
0.00
0.0
8.2
—
33.7
—
0
6
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
45.9
—
0
7
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036005) Urine sediment comments by Light microscopy Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
71
0.96
0.00
1.0
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028917) Waxy casts [#/area] in Urine by Computer assisted method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012403) Metanephrines [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
54
0.95
0.00
1.0
1.2
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
19.4
—
0
5
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_ALZHDEMENT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_ALZHDEMENT | 2.398 [2.17, 2.65] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.03 |
During the follow-up period (1.1.1998 — 31.12.2019), 48483 out of 70483 females with F5_ALZHDEMENT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_ALZHDEMENT | 2.838 [2.47, 3.27] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 27543 out of 38138 males with F5_ALZHDEMENT died.
Mortality risk
Mortality risk for people of age
years, who have F5_ALZHDEMENT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.185% | 0.525% |
| 5 | 1.168% | 2.954% |
| 10 | 3.006% | 7.145% |
| 15 | 5.373% | 13.483% |
| 20 | 9.032% | 22.437% |
Relationships between endpoints
↥Index endpoint: F5_ALZHDEMENT – Dementia in Alzheimer disease
GWS hits: 16
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data